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ABSTRACT
Many amphiphilic molecules (surfactants) possess the ability to aggregate in aqueous
solution to form thermodynamically stable aggregates that have potential for use as molecule
containers and delivery systems in analytical or pharmaceutical applications. However, it is
difficult to release the encapsulated molecules from these aggregates under a controllable manner,
and this problem has dramatically limited the application of these aggregated systems. This
study addresses this problem through fundamental structure modification by development of a
novel redox stimuli-responsive amphiphile capable of forming vesicle aggregates. Aggregate
structure can be adjusted through redox stimulation. The release of agents from the core of the
aggregates containers can be controlled by the same mechanism.
The novel surfactant molecule, Q9 (Figure 1.3), containing a redox stimuli-responsive
moiety was synthesized through seven synthetic steps for this purpose (Chapter 3).

The

molecular structures were characterized by 1H NMR and mass spectrometry analysis methods.
Properties of Q9 in aqueous solution were studied (Chapter 4). The pH sensitivity of Q9 was
explored in a variety of phosphate-buffered saline (PBS) solutions with UV-vis measurements
and 1H NMR experiments; from these studies, suitable pH value was determined for Q9 vesicle
formation. The stimuli-responsive mechanism of Q9 was confirmed by 1H NMR kinetic studies.
The critical aggregation concentration (CAC) was determined by surface tension measurements.
Q9 vesicles were formed by the extrusion technique (Chapter 5). Vesicle characterizations were
evaluated using transmission electron microscopy, light scattering, cryo-electron microscopy and
asymmetrical flow field-flow fractionation. Q9 vesicles were used to encapsulate the model
guest calcein (Chapter 6). Size-exclusion chromatography was used to isolate Q9 vesicles
containing dye calcein. The successful release of calcein from Q9 vesicles was triggered by use
of a chemical reducing agent as observed by the time-dependent increase in calcein fluorescence.
xvi

Based on the data, it appears that the loading volume and number density of Q9 vesicles dictates
their capabilities as an efficient molecule delivery system.

xvii

CHAPTER 1. INTRODUCTION
1.1

Research Goals
The goal of this research is to develop a novel molecular container and delivery system

based on the aggregation of surfactants that can be controlled and adjusted by redox stimulation.
This new stimuli-responsive system has potential for application in drug delivery systems or for
dispensing reagents in microfluidic analysis devices.1-4
Amphiphilic (surfactant) molecules contain both a hydrophobic and a hydrophilic domain
within its molecular structure and can assemble together to form various morphologies.5
Research has confirmed that these aggregates make excellent agent containers or delivery
systems; however, the ability to release the encapsulated agents from these aggregates in a
controllable manner presents a technical barrier. This problem has dramatically limited the real
application of these systems. The study in this dissertation addresses this problem through
fundamental structure modification: by use of a redox stimuli-responsive moiety as part of an
amphiphilic molecule that is capable of forming aggregates.

Aggregate structure and

morphology can then be adjusted by changing structure of the amphiphilic molecule by redox
stimulus, and the release of reagents from the aggregate core can be controlled (Figure 1.1).

Redox Stimulation

Guest

Redox-cleavable amphiphile
Figure 1.1 Release of reagents from the core of a vesicle.

1

Novel amphiphilic molecules containing redox stimuli-responsive functional group were
synthesized for this purpose. The new molecules were characterized and determined to be the
desired structures.

Upon confirmation of the redox stimuli response of these molecules,

aggregates were formed in aqueous environment, and their properties were studied by advanced
analytical methods. Encapsulation and controllable release properties have also been studied by
monitoring the leakage of a fluorescent, hydrophilic dye.
1.2

Research Synopsis

1.2.1

Synthesis of Novel Redox Stimuli-responsive Amphiphilic Molecules
Quinone molecules have been studied for decades to reveal their important role as

electron acceptors in cell membrane and light-induced biological charge separation processes.6-9
These studies have established them as one of the well-known redox systems. Recently, these
redox properties have been used for the construction of advanced redox stimuli-responsive
materials.10-12 Different redox-sensitive kinetic processes can be achieved through different
quinone structures.
Borchard and Cohen discovered the “tri-methyl lock” mechanism based on a quinone
carboxylic structure with three methyl groups.13, 14 From this mechanism, if a reducing agent is
introduced, the quinone structure will be reduced to the corresponding hydroquinone. The three
methyl groups (“tri-methyl lock”) of the hydroquinone structure make it conformationally
unstable; thus, a spontaneous intramolecular cyclization/elimination reaction occurs to produce a
lactone product (Figure 1.2). This mechanism will be utilized in this study to facilitate the
release of encapsulated reagents.
A hydrocarbon chain that contains both a hydrophobic and a hydrophilic moiety is
needed to make the surfactant molecule aggregate in aqueous solution.

Considering both

requirements for redox stimuli-responsiveness and aggregation of amphiphilic chain structures,
2

the novel surfactant molecules were designed with specific structures (Figure 1.3): A “tri-methyl
lock” quinone moiety was introduced on one side of the surfactant structure to give the whole
structure redox sensitivity, and it also served as the hydrophobic part in the amphiphilic structure.
6-Aminocarboxylic acid was used as the carbon chain in the structure, and it was covalently
bonded with the redox-sensitive moiety through the carboxylic group on the tri-methyl quinone.
The carboxylic group on the end of the aminocarboxylic acid molecule provided the hydrophilic
side to the new surfactant. In total, seven steps of synthesis were conducted to achieve the final
surfactant molecule, which was named Q9 (6-(3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa1,4-dienyl)butanamido)hexanoic acid) in this study. The structure of Q9 is shown in Figure 1.3.
Synthesis of Q9 will be discussed in detail in Chapter 3.

O
O
R1
R2
O

O
OH

OH

CH reduction R1
CH3 3
CH3
R2

O
OH

CH
CH3 3
CH3
OH

spontaneous

O
R1

CH
CH3 3 + H2O
CH3

R2
OH

tri-methyl lock
Figure 1.2 Tri-methyl lock reactions.
1.2.2

Structural Characterization
Confirmation of the desired product from each synthesis step was obtained from 1H NMR.

GC-MS, ESI-MS, and HPLC were also used for their characterization. Once Q9 was purified,
NMR kinetic experiments were conducted to characterize the stimuli-responsive mechanism.
The changes in the selected proton signal intensity were monitored after redox stimulation.
Those intensity changes were caused by the chemical structure changes that were triggered by
the redox stimulation, and can be used to confirm the reaction mechanism. Furthermore, the
reaction rate can also be calculated using this method.
3

O
O

OH

N
H

O

Q9

O
6-(3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamido)hexanoic acid
Figure 1.3 Structure of Q9.
1.2.3

Study of the Properties of Novel Redox Stimuli-responsive Amphiphilic Molecules
The unique properties of the newly synthesized surfactants were studied.

The pH

sensitivity was analyzed for future application in an aqueous environment. NMR, and UV-vis
experiments were conducted to explore any potential changes in molecular structures and/or
properties, which are affected by different pH environments. A suitable pH value was chosen for
the following research.
Surface tension experiments were used to measure the critical aggregation concentration
(CAC) of the new surfactant. This concentration is then used as the standard for the following
aggregation development studies.
1.2.4 Development of New Vesicles through Aggregation
The newly synthesized surfactant structure is similar to that of n-alkanoic acid surfactants.
Previous studies have shown that those molecules can aggregate into vesicles under certain
conditions.15-17

The traditional phospholipids-based vesicle generation methodology was

adopted to create vesicles with Q9,18 and employs mechanical extrusion. The experimental
conditions were controlled at a suitable pH value and surfactant concentration. After their
formation, vesicle size was obtained with light scattering. Advanced microscopy methods were

4

also used to study the lamellarity of the vesicles. The disassembly of the vesicles was triggered
by a reducing agent and monitored by dynamic light scattering and TEM. Asymmetrical flow
field-flow fractionation (AF4) was used to explore the size distribution of the Q9 vesicles.
1.2.5

Encapsulation Experiment
A water-soluble dye (calcein) was used as the reagent to be encapsulated inside the Q9

vesicles. Calcein is a self-quenching dye whose fluorescence is quenched when encapsulated
inside the vesicles at a high initial concentration. In order to encapsulate the calcein, a solution
of the Q9 surfactant and calcein at a concentration higher than the self-quenching concentration
was extruded. A preparative size-exclusive chromatography column was then used to separate
the vesicles from the free calcein. Salt concentration and pH were controlled carefully during
this separation process. Fluorescence kinetic experiments were then set up to monitor the timedependent fluorescence signal upon application of redox stimulation. Based on the expected
redox-stimuli responsive mechanism, the introduction of a reducing agent should cause a
disconnection in the surfactant and subsequent disassembly of the vesicles. Thus, calcein is
released, it is diluted to a value less than its self-quenching concentration, and the increase in
calcein fluorescence can then be observed.
1.3

Background

1.3.1

Vesicle Aggregation
Surfactant molecules, also called amphiphilies, contain both a hydrophobic part and a

hydrophilic head group.

When these molecules are dissolved in an aqueous solution, the

hydrophobic part tries to minimize the contact area with water molecules. This phenomenon is
called the hydrophobic effect and can cause the formation of different aggregates.19 Inside the
structure of aggregates, a concentrated hydrophobic part is surrounded by the hydrophilic moiety

5

that contacts water molecules directly. This construction produces macro-homogenous systems
(solution) with many “different” micro-phase structures (aggregates) inside.
Based on the variety of molecule structures, solution systems, and treatment methods,
amphiphilic molecules can aggregate into different morphologies that include ordinary and
inverse micelles, liquid crystals, bilayers, vesicles, and microemulsions.20 Among them, research
on vesicle structures has become increasingly important, because these aggregates possess
potential for use as water-soluble reagent containers and delivery systems.
A bilayer structure formed by amphiphilic molecules is the basic construction unit for
vesicles (Figure 1.4). The amphiphilic molecules are well organized inside the vesicles: the
hydrophilic polar heads face the aqueous surroundings, and the hydrophobic parts constitute the
interior of the bilayer. In the simplest case, the bilayer just forms planar structures (Figure 1.4);
however, it is possible that the bilayer can be curved to form closed, spherical objects called
vesicles. Vesicles can be many different sizes, such as small unilamellar vesicles (SUV, radius 4
– 20 nm), large unilamellar vesicles (LUV, radius 50 nm – 10 µm), and multilamellar vesicles
(MLV). Generally, unilamellar vesicles are more likely to be observed in dilute systems, while
MLVs are typically found in concentrated systems.

Hydrophilic
Head

Hydrophobic
Tail

Figure 1.4 Bilayer planar structure.
The formation of vesicles from surfactants can be achieved through dispersion of lamellar
bilayer, by dilution, input of external force, or spontaneously depending on amphiphile
molecular structure. The detailed mechanism for each condition is still under investigation.
Traditionally, three classic techniques are used to cause formation of phospholipid vesicles:
6

sonication, thin-film hydration, and extrusion.18 Among them, the extrusion technique is the
most widely used. Using this technique, multilamellar surfactant is pushed through an extruder;
the strong shear force reorganizes the lamellar sheet structure into vesicles. A membrane filter
with a given pore size will cause phospholipids to form vesicles of approximately same size as
the membrane pores.21
Phospholipid vesicles have been studied for a long time as classic vesicle models. These
particular vesicles are formed by phospholipid molecules that usually possess two hydrophobic
chains as the “tail” structure. Recent research has confirmed that vesicles can also be generated
by single-chain surfactants.15,

22, 23

It has been suggested that these single-chain vesicle

aggregates performed an important role in the early stages of life.24 Szostak pointed out that
these vesicles can provide a spatial microenvironment for photo-metabolic reactions, or a
mechanism for the spatial confinement of genetic polymers.17
Walde studied single-chain vesicles formed by decanoic acid,22 whose structure is such
that micelle aggregates form in aqueous solution. Based on Walde’s study, the ionization status
of decanoic acid affects aggregate formation. Highly deprotonated decanoic acid (decanonate)
easily forms micelles; however, when the ratio of unionized decanoic acid is increased in
solution, vesicles can be formed. Walde mixed decanoic acid and the corresponding decanonate
salt together under a variety of concentrations, and applied the titration method to adjust the pH
of these solution systems (Figure 1.5).
The experiment results showed that these solutions undergo similar changes even though
the concentrations are different. The solutions remained transparent if the pH was greater than
8.1, which indicated predominately micelle-style aggregates in the solution when decanoic acid
was highly deprotonated. When the pH was decreased to 8.1, the solution started becoming
turbid, indicating a change in aggregate formation.
7

Using microscopy, the cause of these

changes has been confirmed to be the result of vesicle formation. To confirm this result, a mixed
solution of acetic acid and the corresponding acetate salt has been used to perform the same
titration experiment. No phase change can be observed during the pH adjustment because no
aggregates were formed using this system. Walde pointed out that when the pH was decreased
into the range of 6.5 to 8.1, a well-balanced solution of protonated and deprotonated decanoic
acid was achieved, and this balanced condition was key to form the vesicles.

Figure 1.5 Titration experiments on (decanoate + decanoic acid) and (acetate + acetic acid)
system. Adapted from Ref 22.
Blanchard also studied this decanoic acid solution system25 and clearly confirmed that
vesicles form from this single-chain amphiphile between pH 6.5 and 8.1 at concentration 100mM.
The formation of micelles and vesicles could be observed from this single-chain surfactant
8

solution by TEM studies (Figure 1.6). These research results indicate that ionization plays an
important role in aggregate formation from these single-chain fatty acid surfactants, and pH can
be adjusted to control the aggregate type so as to generate vesicles.

Figure 1.6 TEM image of decanoic acid/decanoate (a) vesicles and (b) micelles. Adapted
from Ref 25.
Szostak studied the growth of this kind of vesicle from another point-of-view:
transforming the micelles into vesicles.16 It was pointed out that these fatty acid vesicles possess
different properties in comparison to those phospholipid vesicle counterparts. One difference is
that although these vesicles still exist as stable supramolecular structures, their molecular
components are in a rapid, dynamic exchange process with the surrounding solution and with
each other. It has also been suggested that the spontaneous assembly of fatty acid vesicles from
9

alkaline micelles is an autocatalytic process. A certain sized oleate vesicle was used as a seed to
initiate growth of the vesicles by incorporating additional oleates supplied by oleate micelles.
Fluorescence was used to follow fatty acid vesicle growth. A non-exchanging, membranelocalized fluorescence resonance energy transfer (FRET) dye was applied here to measure the
increase in vesicle surface area as the micelles transfer into vesicles. The experimental results
showed that there are two mechanisms for vesicle size increase (Figure 1.7). In one mechanism
oleates were transferred from micelles into vesicle directly by coating the preformed vesicles. In
another mechanism, oleates formed aggregated intermediates first, then transferred into vesicles.
The vesicle formation process is hard to control and monitor. This study provides a novel
way to observe how single-chain fatty acid vesicle size can be changed by adopting micelles
surrounded in the solution. This finding will be useful on the monitoring of vesicles size change
in the future vesicle studies.
coating the preformed vesicle
(f ast phase)

Growing
Vesicle

aggregated intermediates
(slow phase)

Figure 1.7 Proposed scheme of dynamic processes occurring between fatty acid micelles
and vesicles.
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In another article published by William R. Hargreaves and David W. Deamer, C8-C18
single-chain carboxylic acid amphiphiles were studied to understand the physicochemical
conditions for the formation of membrane structures.15 A variety of characterization techniques
were applied in this research to image vesicles, such as trapping of ionic dyes, negative-stain
microscopy, and freeze-fracture electron microscopy.

One interesting new method, phase-

contrast microscopy, was utilized to image the vesicles wherein some solutes such as sucrose
were added into the vesicle solution, which then creates differences in the refractive index to
make vesicles appear brighter in the microscope.
1.3.2

Redox-responsive Aggregates
The stable chemical environment inside the aggregates, their nanometer size, and their

long-term storage stability have enabled vesicles to be used in many different areas.

For

example, vesicles can be used as drug delivery systems to transport drugs to target position and
protect those drugs from elimination by the body’s immune system.26, 27 Vesicles can also be
used as reagent-dispensing systems to delivery reagents in microfluidic analysis devices to
enable advanced lab-on-a-chip technology. 1
Although vesicles have many advantages for a variety of applications, there does exist a
technical barrier to overcome in order to utilize vesicles system: the controlled release of the
encapsulated reagents from the vesicles. Researchers have tried different methods to achieve this
control.

Many of those works have focused on solving this problem from a fundamental

structure point of view: to modify the surfactant structures to give them specific stimuliresponsive properties.4, 28-30 The aggregates formed from these surfactants are easily controlled
by the same stimulation mechanism. Although some systems have been developed using this
idea, their structure and properties are not well-defined. More studies still need to be conducted
in order to develop new systems.
11

Redox-responsive surfactants are good candidates for stimuli-responsive structures by
providing precise control over the disassembly of vesicles (through a reducing agent or an
applied potential). Generally, these structures have a redox-sensitive functional group within the
molecular structure. Upon a redox-stimulation, the structure of those sensitive groups changes
and initiates the disassembly of the vesicles.
Many scientists have tried to synthesize these redox-responsive surfactants with different
functional groups. For example, the Manners group has synthesized a new redox-sensitive
amphiphilic structure,4 a diblock copolymer that employs polydimethylsiloxane (PDMS) as a
hydrophobic block and polyferrocenylsilane (PFS) as a hydrophilic block.

Based on their

experiments, this newly synthesized amphiphilic structure can self-assemble into vesicles in
water and has been confirmed by TEM experiments. PFS is an electroactive block that is
controlled by redox stimulations. The previous study has shown that the redox reaction of the
ferrocenyl group causes the change in the hydrophilic property of the surfactant.

31, 32

It is

predicted that vesicles generated by this diblock copolymer can be controlled by redoxstimulations; however, the goal of this project has yet to be demonstrated.

Although the

structure is well-designed and vesicles are formed, no evidence has been shown that vesicles
morphology can be adjusted by redox stimulation.

No reasons were cited for this, which

indicates more research is still needed on this system.
Bhattacharya’s group30 has also developed three new surfactant structures that use an
anthraquinone moiety as the redox-sensitive group. A hydrocarbon chain structure is covalently
attached onto the anthraquinone. Based on their study, vesicles can be formed by sonicating
these surfactants for several minutes in water. Anthraquinone is a redox-sensitive group that can
be reduced into the corresponding hydroquinone upon introduction of a reducing agent or
application of a reducing potential. Once it is reduced, the polarity of the group dramatically
12

changes; thus, vesicle morphology can be adjusted. UV-vis experiments have clearly shown the
production of the hydroquinone product after introduction of dithionite (S2O42-), confirming that
the designed mechanism is working. However, no guest release studies have been demonstrated
to date.
Some strategies to develop new redox-responsive surfactants can be derived from these
examples discussed above: choose a redox-sensitive moiety as the polar group and attach a
hydrocarbon chain covalently-bonded to a hydrophilic head group. Previous works confirmed
that these kinds of amphiphilic structures can aggregate into
vesicles.4, 30 Meanwhile, the polarity change caused by redox-stimulation is capable of changing
the amphiphilic nature of molecules and disassembling the vesicles to controllably release the
payload. Studies have shown some progresses in developing redox-responsive aggregates, but
the properties of those developed systems are still not well-defined. 4, 30
Although ferrocenyl has been confirmed as a redox-sensitive structure in previous studies,
it can not be shown if this redox reaction will actually drive the change in vesicle morphology
that is described in Manner’s paper. The work from Bhattacharya’s group is encouraging, but
their vesicles can only remain stable in storage for several hours based on light scattering data
(suspected that the anthraquinone group photo-decompose), which will limit their application.
Clearly, the development of new redox-responsive aggregates is very challenging work due to
the difficulties with new surfactant syntheses, the complex mechanism of vesicle formation, and
the limited methods for disassembling vesicles.
1.3.3 Quinonoid Compounds
Quinonoid compounds have been studied over many decades as the prototypical example
of organic redox systems.33 Usually, they are ring structures containing a cross-conjugated
system. Quinone compounds can undergo electrochemical reactions, and the reduced
13

hydroquinone product will have a different polarity from the initial quinone structure. The halfreaction is a reversible reaction:
Equation 1.1
A particular quinone compound has been found to play a very important role in biological
activity for most living systems during the synthesis of adenosine triphosphate (ATP).34, 35 In the
1960s, people already knew that ATP was the energy source for most of life, but it was still
unclear how ATP was generated until Nobel Laureate Peter Mitchell illustrated his chemiosmotic
theory. Based on this theory, it is an electrochemical gradient generated in the cell membrane
that drives the synthesis of ATP.34, 36 A series of redox processes generate the electrochemical
gradient in the cell membrane, and a quinone compound called ubiquinone performs a very
important role to make these processes work normally.

Figure 1.8 Structure of ubiquinone.
Ubiquinone is a lipid-soluble structure and is able to move freely inside the cell
membrane, enabling ubiquinone molecules to shuttle electrons between immobile, larger
complexes that are imbedded inside the cell membrane. The redox reactions of ubiquinone are
similar to the redox reactions of other quinone structures. It is very interesting to see that even
nature has utilized quinone redox properties for one of the most important processes in life.
Furthermore, cell membranes resemble a vesicle structure; the presence of ubiquinone in this
environment indicates the possibility for future incorporation of quinones in “artificial” vesicles.
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Recent studies have shown that quinone compounds can also work as bioactive drug
candidates for tumor cell treatment.10, 37-39 DT-diaphorase is a quinone oxidoreductase enzyme
that exists in a wide variety of cells,40 and it can reduce quinone compounds to the corresponding
hydroquinone. Researchers at the National Cancer Institute have screened a variety of tumor cell
lines to check their specific enzyme activities.38 Three different enzymes were chosen for these
studies, and the results showed that for every scanned tumor cell line, DT-diaphorase presented
an obviously higher enzyme activity compared to the other two enzymes included in the study.38
This extremely high enzyme activity for DT-diaphorase in cancer cells could be used as the
trigger for the stimuli-response reaction mechanism, the reduction of quinone-based bioactive
compounds will cause the degradation of the vesicle and release of the anti-cancer drug.
1.3.4 “Tri-methyl lock” Mechanism of the Quinone Compound
In 1972, Cohen and Borchard published their research concerning a series of quinone
compounds that contained a 3-methylene carboxylic acid, a compound capable of undergoing a
ring cyclization/lactonization reaction upon reduction to the hydroquinone.13,

41, 42

These

structures and the corresponding ring cyclization/lactonization reactions have been studied in the
following years; new stimuli-responsive molecules were designed from these studies. 12

Figure 1.9 “Tri-methyl lock” mechanism.
Research has shown that molecular structures containing two methyl groups at the
benzylic position together with a proximal methyl group on the ring, referred to as the “trimethyl lock”, will exhibit enhanced lactonization rates. Upon reduction, an intramolecular
15

cyclization/elimination reaction occurs automatically following the formation of the
hydroquinone; hence, the “tri-methyl lock” mechanism. The spontaneous lactonization reaction
occurs because the three methyl groups create increased strain energy on the ring structure,
which facilitates nucleophilic attack at the carbonyl carbon. The “tri-methyl lock” mechanism
and the structures of the compounds involved in this process are shown in Figure 1.9.12
By varying the functional group (XR) adjacent to the carbonyl, the “tri-methyl lock”
mechanism can be extended to other applications that also utilize this cyclization/elimination
event. For example, researchers have used these “tri-methyl lock” quinone structures to develop
prodrugs as delivery systems wherein HXR is some kind of drug. In particular, Borchardt and
coworkers have reported that hydroxyl amide lactonization can be used as a potential esterasesensitive amide prodrug.37-39

The mechanism for the redox-sensitive and esterase-sensitive

system is shown in Figure 1.10.39

Figure 1.10 Mechanisms for utilizing “tri-methyl lock” mechanism for prodrug release.
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In this application, the quinone moiety can be reduced under certain chemical conditions
(step 1b), and then the following intermediate undergoes lactonization to release the potential
drug compound (step 2). If an ester moiety is present on the hydroquinone, then the rate of
lactonization depends on the rate of enzymatic or chemical hydrolysis of the initial structure
(step 1a).39 These structural designs helped to develop a prodrug system that is triggered by
either an esterase or reducing agent.
Another paper, published by Mrksich’s group, described a double side-chain structure
that is also based on a “tri-methyl lock” quinonoid compound.43 The purpose was to develop a
new class of dynamic electroactive monolayers on surfaces that can selectively release
immobilized ligands, which is very important to bio-interfacial science studies. The monomer
structure of this double chain structure is illustrated in Figure 1.11.

O

O

O

NH2

O
O

O

Figure 1.11 A quinone propionic ester with a bi-functional group.
The side chain containing the double bond in Figure 1.11 was used to connect the selfassembled monolayers (SAMs) of alkanethiolates onto gold surfaces while the other side with a
terminal amine was used to capture biotin ligands. When a reduction potential was applied
through gold, the quinones convert into the corresponding hydroquinones, which then undergo
the cyclization/elimination reaction and release the biotin ligand. The “tri-methyl lock” in this
structure serves to increase the rate of biotin release.

This study combines self-assembly

monolayer, the redox property of quinone structures, and biotechnology to demonstrate the great
potential for mechanistic studies in cell biology.
17
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CHAPTER 2. MATERIALS AND METHODS
2.1

Chemicals
The following chemicals were purchased from Sigma-Aldrich and used as received:

trimethylhydroquinone (97%), methanesulfonic acid (99.5%), dimethylacrylic acid (97%), ethyl
acetate (99.5%), sodium bicarbonate (99.5%), sodium chloride (99.5%), magnesium sulfate
(99.9%), deuterated chloroform (99.9 atom%), anhydrous tetrahydrofuran (99.9%), triethylamine
(99.9%), anhydrous dichloromethane (99.9%), potassium carbonate (99%), hexane (99%),
anhydrous chloroform (99.9%),
N-bromosuccinimide (99%), 1,3-dicyclohexylcarbodiimide (99%), acetonitrile (99.9%), acetone
(99.9%), 10% palladium on carbon catalyst powder, ethanol (99.9%), fuming sulfuric acid (18M),
formic acid (96%), sodium dithionite (85%), calcein (93%), sodium phosphate dibasic (99%),
sodium phosphate monobasic (99%), sodium phosphate (96%),

isobutylene (99%).

N-

hydroxysuccinimide (Aldrich 97%) was purified by recrystallization prior to experiments.
Additionally, N-benzyloxycarbonyl-6-aminohexanoic acid (Novabiochem, 90%), sephadex G25
gel (GE healthecare), sodium hydroxide (Fisher, 98.6%), 32-63 µm neutral silica gel having 6
nm pore size (Alltech), silica gel TLC plate (Alltech), were also used in these experiments.
Water for these experiments was purified and deionized (18 MΩ-cm) through the use of a
Barnstead-Nanopure water filtration system.
2.2

Methodologies

2.2.1

Extrusion Technique for Development of Vesicle Aggregates
Solid Q9 (2.1 mg) was dissolved in 10 mL dichloromethane (DCM), and the solvent was

evaporated under vacuum in a round bottom flask (RBF) to form a dried homogenous Q9 thin
film. Phosphate buffered saline (PBS) solution (50 mM with NaCl 50 mM, 0.7 mL, pH 7.8)
solution was filtered through a sterile Anotop filter (Whatman, 0.02 µm pore size/10 mm
22

diameter), and added into the RBF to hydrate the Q9 dried film for 2 hours. The flask was then
vortexed for 15 mins. A hand-held, mini-extruder from Avanti Polar Lipids with 100 nm pore
size Nuclepore polycarbonate track-etched membrane (6-11 µm thickness) was used to extrude
21 repetitions the Q9 molecules for forming vesicles, Figure 2.1.

Solution Flow

Solution Tube

100 nm
Membrane
Figure 2.1 Extrusion.
Before the experiment, one polycarbonate track-etched membrane (Nuclepore,100 nm, 611 µm thickness) was fitted in the middle part of extruder across the internal solution channel.
Two Gas-Tight syringes were connected on each side of the solution tube. One syringe was
filled with vortexed 10 mM Q9 in pH 7.8 PBS. This syringe was pushed by hand to force the
solution through the membrane into the opposing syringe. Then it was pushed back to the
original syringe. This process was repeated 20.5 times. The strong shear force generated as the
solution is pushed through the membrane promotes vesicle formation.1-3
2.2.2 Preparation of Samples for Light Scattering
All sample cells for the LS experiment were thoroughly cleaned to remove any dust. The
cleaning procedure included sonicating glass sample cells for 20 mins, a rinse in Nano-pure
water, and drying in a laboratory oven.
Q9 solutions were prepared in pH 7.8 PBS solution (50 mM with NaCl 50 mM) and then
filtered through a sterile Anotop filter (Whatman, 0.1 µm pore size/10 mm diameter). They were
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then treated through the extrusion process as described above. The extruded samples were placed
in the dust-free sample cells for the LS measurement.
2.2.3 Dynamic Light Scattering
Dynamic light scattering is a technique that measures and correlates the change in
scattering light intensity through a liquid sample and is based on the fact that free particles inside
the solution undergo a “random walk” based on the theory of Brownian Motion. Thus, the
diffusion coefficient value (D) of sample particles can be derived from the change of scattered
light intensity in the time frame of a given experiment. The autocorrelation functions recorded in
the experiment make the measurement of D possible. If the particles present as a spherical
structure, The Stokes-Einstein equation (Rh=kT/6πηD) can be applied in order to calculate the
hydrodynamic radius of a given particle.4
Dynamic light scattering experiments were conducted using a Zetasizer Nano Instrument
(Malvern, Worcestershire). Carefully cleaned glass sample vials were used and were prepared
according to the preparation of sample cells referred to the section 2.2.2.

Experiment

temperature was held constant at 25 oC and was stabilized before the measurement. The buffer
viscosity parameter was calculated by the software of the instrument using the concentration of
the sodium phosphate present.
2.2.4

Surface Tension Measurement
Surface tension measurements of Q9 in PBS solution were performed using a Sigma 703

tensiometer (KSV Instruments, Monroe, CT) by using the du Nuoy ring method. A platinum
ring of 5.99 cm mean circumference (CSC Scientific, Fairfax, VA) was hung on a microbalance.
The force applied to this ring was recorded through this microbalance.
A 2.0 mL solution sample of Q9 was placed in a home-made 10 mL glass cup.

The

platinum ring was cleaned with ethanol and dried under a nitrogen gas flow before the
24

measurement. Then, the ring was submerged into the solution and raised up slowly until it was
no longer in contact with the solution in the glass cup. This operation was repeated three times;
each time the maximum force on the ring was recorded as the surface tension. Average values of
surface tension and standard deviations were calculated from these sets of runs.
Read Out
F

Ring

Solution Surface

Solution

Surface Tension

Figure 2.2 Surface tension measurement by du Nuoy ring method.
In order to calculate the CAC of Q9, a series of surface tension measurements were
conducted on Q9 samples. Eleven Q9 samples were prepared in PBS solution (50 mM with
NaCl 50 mM, pH 7.8) with the concentrations ranging from 0.2 mM to 14 mM.
Samples were tested from the highest concentration to the lowest concentration. The surface
tension of pure solvent (buffer) was also measured, giving the highest value in this series of
experiment results. A surface tension versus concentration curve was plotted and the CAC value
was determined from this curve.
2.2.5

Theory of Critical Aggregation Concentration
When surfactant molecules dissolve in water, they are likely to migrate to the air-water

interface because of the insolubility of the hydrophobic moiety of the surfactant. The non-polar
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group of the molecule is oriented in the air phase. The concentrated hydrophobic structure at the
interface results in a decrease of surface tension.
Concentrated surfactant at the air-water interface allows for a increase in the repulsive
forces between adjacent molecules. When the concentration is increased to a certain degree, the
repulsion force is big enough to prevent more surfactant being taken up at the interface. Thus,
aggregation of molecules ensues.

The concentration at this moment is called the critical

aggregation concentration (CAC).

Above the CAC, any further surfactant added into the

solution forms aggregates instead of inserting at the water-air interface. The surface tension
should stay relatively stable regardless of whether more surfactant is added to the solution.
This surface tension property can be used for the determination of the CAC. Generally a
group of water solutions is prepared having different surfactant concentrations. The surface
tension of each solution is measured.

In the low concentration range, the surface tension

decreases as a result of the increasing surfactant concentration due to the migration of the
surfactant to the air-water interface. When the surfactant concentration is above the CAC, the
surface tension becomes stable due to the formation of aggregates. Thus, the surface tension
data can be plotted versus solution concentration; the concentration related to the “turn over”
point in this plot will be the CAC.5
2.2.6 Mechanism of Asymmetrical Flow Field-Flow Fractionation (AF4)
AF4 systems were developed to separate and characterize particles in solution.6-8 The
sample is injected into a channel with a lamellar flow along the channel direction, another flow
of the same solvent system is applied orthogonally to the first flow by passing solvent through a
membrane on the bottom of the channel. The membrane through which the orthogonal flow
passes is designed to have size-exclusion capabilities; the pore size of the membrane is smaller
than the sample particles to prevent the injected sample particles from being lost. Thus, particles
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inside the sample are pushed closer to the membrane as they move through the channel carried
by the lamellar injection flow. Those particles present different distance from the membrane as
well as the different flow rate, as they are carried in the lamellar flow, depending on their sizes
and the strength of the orthogonal flow.

Finally, they will elute out at different times due to

flow velocity differences. The mechanism of this technique is shown in Figure 2.3. To achieve
the best separation result, both the lamellar and orthogonal field flow is adjusted to optimize
particle separation by adopting different programming methods. The programmed
field-flow method is called AF4 technology and it was applied to the Q9 system.6-9

Figure 2.3 The mechanism of AF4 separation based on the particle sizes. Adapted from
Reference 7.
2.2.7

AF4 Studies on Extruded Q9 Sample
Q9 aggregates were separated using an Eclipse 2 AF4 system (Wyatt Technology Corp.,

Santa Barbara, CA). An Agilent 1100 HPLC system (Agilent 1100 isocratic pump, Agilent 1100
autosampler, and Agilent 1100 degasser, Agilent Technologies, Palo Alto, CA) was used for
injection of the samples and delivery of solvent through the AF4 system. The AF4 channel was
assembled with a 350-µm-thick Mylar spacer; the membrane used was made of regenerated
cellulose with a 10 kDa molecular weight cutoff (Wyatt). Three detectors were used for the
analysis: a Heleos, multi-angle light scattering (MALS) with a QUELS (DLS) detector (Wyatt
Technology Corp., Santa Barbara, CA); an Optilab rEX Differential Refractive Index detector
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(Wyatt Technology Corp., Santa Barbara, CA) at 658 nm; and a Waters 484 UV-Vis detector
(Waters, Milford MA) at 280nm.

Data acquisition of the root mean squared (rms), and

hydrodynamic radius (Rh) value were calculated using Astra V software (Wyatt).
For the experiment, PBS solution (3.0 L, 50 mM with NaCl 50 mM, pH 8.0, containing
200 ppm NaN3) was prepared at 40 mM concentration, then filtered through a 100 nm membrane
for use as the mobile phase. Q9 aggregate samples (3.0 mg/mL) and DOPC vesicle samples (1.0
mg/mL) were prepared in the same buffer solution by the extrusion method with a 100 nm
membrane.

The DOPC sample was used as the reference for the flow control method

development.
2.2.8 Preparative Size-Exclusion Chromatography
Size-exclusion chromatography is widely used to separate and characterize particle
samples with various particle sizes in polymer and biological studies.10 In this research it was
used to separate Q9 vesicles in solution. Sample solutions having particles with polydisperse
size distribution are introduced into a preparative
size-exclusion chromatography column that is packed with beads of porous material. Small
particles in the solution can go into the pores inside these beads. Thus, they move slowly there
until they exit from the pores because of the hydrodynamic shielding effect.

Big

particles/molecules can not enter the pores; they move rapidly through the void volume between
the beads. Thus, different particles elute from the column at different times: big particles move
out quickly, small particles come out later.
The preparative size-exclusion column used here is an in-lab prepared column. Sephadex
G25 gel (GE Healthecare, Piscataway, NJ ) was used for the column packing medium. The
sephadex gel (10 g) was hydrated with the same PBS that was used for the eluent (pH 7.8) for 10
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hours, then poured slowly into a 100.0 mL titration burette and allowed to settle in order to pack
the column.
The particle separation was conducted under air pressure. Q9 vesicle samples that were
developed by the extrusion treatment were introduced at the top side of the column via a glass
pipette. The volume of PBS solution in the burette was maintained to act as the mobile phase.
Particles were separated based on the theory explained above. The effluent was collected at
consistent time increments as samples to be analyzed. In accordance with the mechanisms
working in the preparative size-exclusion column, Q9 vesicles were contained in the earliest
collected effluent samples.
2.2.9

Dye Encapsulation and Release Experiment
Calcein, a water-soluble dye, was explored to study the encapsulation ability of Q9

aggregates. A 50 mM concentration of calcein in pH 7.8 PBS (0.1 M with 0.1 M NaCl) was
extruded simultaneously with 3 mg/mL of Q9. Calcein was self-quenching under this
concentration. The concentrated calcein was maintained, as well as the self-quenching status,
when it was encapsulated inside the Q9 vesicles, because the Q9 vesicle protect it from dilution
in the PBS solvent.11 The extruded solution was eluted with pH 7.8 PBS solution (0.1 M with
0.1 M NaCl) through an in-lab prepared size exclusion column (sephadex G25 gel, GE
healthecare) to separate the calcein-containing Q9 aggregates from free calcein. After separation
by preparative size-exclusion column, the fluorescence intensity of Q9 aggregates containing
calcein was monitored with a luminescence spectrometer (PerkinElmer, LS50B, Waltham, MA)
in order to observe the impact of adding Na2S2O4, a chemical reducing agent.
2.2.10 Preparation of Samples for Transmission Electron Microscopy
Microscope grids and a storage box were purchased from Electron Microscopy Sciences.
Grids used for experiments were the 400 mesh carbon-coated Cu type (CF400-Cu-25). For
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sample analysis, the grid was carefully placed into a 150 mm x 15 mm polystyrene Petri dish
cover (Fisher Scientific) with carbon side facing up. One small drop of sample solution was
deposited on the grid with a 2 µL micropipette. Five minutes later, it was removed by blotting
with a small piece of sterile filter paper, being careful not to displace the aggregate sample
attaching to the grid while blotting. A negative stain method was used for sample imaging. A
small drop of 2% uranyl acetate (UO2(CH3COO)2·2H2O water solution was deposited on the
sample loaded grid, and allowed to sit for 2 mins before removed by blotting as previous
described.12, 13
A JEOL 100 CX transmission electron microscope with an electron acceleration voltage
of 80 kV was employed for the experiment (JEOL USA, Inc., Peabody, MA). Tweezers were
used to place the grid onto the sample holder inside the TEM microscope. Liquid nitrogen was
used as the cooling agent during the experiment process. Kodak electron microscope film
(vendor number 1662238) with dimensions of 3.25" x 4" was used for the experiments and was
developed and fixed according to the operation menu from Kodak. Negatives were scanned into
a computer and edited with Photoshop software (Adobe, San Jose, CA).
2.3

Instrumentation

2.3.1

Nuclear Magnetic Resonance Spectroscopy (NMR)
Proton NMR experiments were performed on several Bruker instruments, including a

DPX-250, ARX-300 and DPX-400. 1H kinetic experiments were performed on Bruker ARX-300
instrument. All these experiments were conducted under at room temperature. For 1H NMR
kinetic studies, 23 1H NMR experiments were run for 300 minutes after the addition of 5
equivalents of solid reducing agent, Na2S2O4. During each experiment, NMR spectra were
recorded at various time points to measure the change in proton signals during the 300 mins
experiments.

Each 1H NMR spectrum was integrated to achieve the relative area of the
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absorption peaks for each experiment. The change in area of selected peaks was used as the
index to monitor the reaction kinetic process.
2.3.2 Gas Chromatography Mass Spectrometry (GC-MS)
GC-MS analysis was performed with a Varian Saturn 2200 GC/MS (Varian, Palo Alto,
CA). This instrument was equipped with a CP-3800 GC and the 2000 Series Ion Trap MS with
an automatic injection mode. Chloroform was used as the solvent for the sample preparation.
The mass range of the instrument is from 10 to 650 m/z. Software utilizes a DB5 control method
for all analyses (Injector temperature 250 ºC, flow pressure 0.1 psi, column oven temperature
280 ºC).
2.3.3 Electrospray Ionization Mass Spectrometry (ESI-MS)
An Applied Biosystems (Foster City, CA) QSTAR XL quadrupole time-of-flight MS
with nano LC system was utilized for high-resolution ESI-MS analyses. Samples were measured
with a mass accuracy below 4 parts per million (ppm).
2.3.4

Cryogenic Electron Microscopy (CryoEM)
CryoEM experiments were conducted at National Center for Macromolecular Image

(Baylor College of Medicine, Houston, TX). The sample was prepared for imaging by means of
vitrification of frozen hydrated samples.14 This method enables the sample to retain its solution
properties with the fewest possible artifacts. A Quantifoil (Quantifoil Micro Tools EmbH, Jena
Germany) 400 mesh holey carbon copper grid was placed in the Vitrobot (FEI, Hillsboro OR)
where temperature and relative humidity were regulated.

The 2.5 µL aliquot of sample was

applied to one side of the grid, filter paper was used to remove excess liquid on the grid by an
automatic blotting process.

Then the grid was rapidly plunged into a cup of liquid ethane,

thereby freezing the sample almost instantaneously. Vitrification of the sample on the grid was
achieved during this process; the resulting “glues” can be examined by the electron microscopy.
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The grid was then transferred to a storage holder submerged in a liquid nitrogen tank where it
was kept until use (in 7 days).

Microscopy was carried out using a JEOL 2010F transmission

electron microscope (JEOL, Tokyo Japan) operated at 200 kV under loose dose conditions, and
the specimen was maintained at -203 ºC by a Gatan Model 626 cryostage (Gatan, Pleasanton
CA). Images were recorded with Gatan US4000 4k x 4k charged-coupled device (CCD, Gatan,
Pleasanton CA) camera and processed using the EMAN software package.15
2.3.5

Ultraviolet-visible (UV-vis) Spectroscopy
UV-vis absorption measurements were performed on a Cary 50 Bio UV-vis Spectrometer

(Varian, Palo Alto, CA). The emission source in this instrument is a Xenon flash lamp and is
able to scan a sample through a range of wavelength from 200 to 1000 nm in 80 seconds. Scan
ranges were selected depending on the solvent system used and the purpose of analysis. Medium
scan rate was chosen. A quartz cuvette or a polystyrene UV-vis cuvette (Fisher Scientific,
Pittsburgh, PA) with 1.0 cm path length were used as the sample cells for the absorbance
measurements. Before each sample measurement, a “blank” sample (solvent) was run to allow
for background subtraction.
2.3.6

Fluorescence Spectrometry
An LS 50B Fluorescence Spectrometer (Perkin Elmer, LS50B, Waltham, MA) was used

for fluorescence measurements. A pulsed Xenon discharge lamp (7.3 W average power at 50 Hz)
was utilized as the light source and the operation of the instrument was controlled with FL
Winlab software. The software enabled a dynamic process measurement up to 1500 minutes
with adjustable interval time scale measurements of the fluorescence intensity change. A 10×10
mm (3.5 mL) quartz cell was used as a cuvette during analysis.
Dynamic fluorescence experiments were conducted on Q9 vesicle samples with calcein
encapsulated; the excitation wavelength (495 nm) and the emission wavelength (515 nm) of
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calcein were used in the dynamic operation mode to monitor the fluorescence change of the
sample. The whole dynamic experiment time was continued for 1500 minutes; the fluorescence
intensity was recorded every 5 minutes in the experiment setup. The change of the fluorescence
intensity during the dynamic experiment was plotted.
2.4
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CHAPTER 3. SYNTHESIS OF A NOVEL SURFACTANT
3.1

Introduction
The first goal of this project is to synthesize a novel, stimuli-responsive surfactant

containing a quinone moiety as the redox-active trigger. The reduction of quinone compounds
can be easily achieved through multiple methods,1-4 and the reaction process can be monitored
by kinetic studies.5-10

Thus, the redox sensitivity of this new surfactant structure can be

characterized.
The first chapter introduced the redox mechanism of tri-methyl lock quinone structures,
which readily to conduct cyclization reaction due to the unique high strain energy of the trimethyl lock structure.6, 8, 11, 12 Many researchers have already successfully developed and studied
redox-responsive structures based on the tri-methyl lock mechanism; however, most of these
systems were designed for pro-drug applications. 13-15
In this study, the tri-methyl lock quinone structure will be used to build the redoxresponsive property into the novel surfactant molecule, while a hydrocarbon chain containing the
suitable hydrophobic and hydrophilic parts will be incorporated to promote aggregation.16 Thus,
the quinone will serve as both the redox-sensitive group and as a part of the hydrophobic moiety.
The 6-aminohexanoic acid chain will be attached through a carbonyl group and will serve as the
hydrophilic head group. This desired novel surfactant will henceforth be referred to as Q9
(Figure 3.1).

Figure 3.1 Structure of Q9.
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The Q9 structure is amphiphilic and should aggregate in aqueous solution. The quinone
moiety serves as the redox, stimuli-responsive group in this structure.

In the presence of a

reducing agent, Q9 is reduced to the corresponding hydroquinone, initiating the tri-methyl lock
mechanism to facilitate the intramolecular cyclization/elimination event that breaks the backbone
of Q9 and liberates a lactone and 6-aminohexanoic acid (Figure 3.2). Therefore, the disruption
and unraveling of these aggregates can be controlled and adjusted through modification of
structural elements.
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Figure 3.2 Q9 reduction and intramolecular cyclization/elimination event.
3.2

Synthesis Discussion
The first part of this synthesis was to develop the tri-methyl lock quinone moiety, which

was based on similar routes as those developed by Cohen and his coworkers.6-11 Lactone 2 was
achieved via a 1,4- Michael addition of 3,3-dimethylacrylic acid to the trimethyl hydroquinone 1.
Hydrolysis and subsequent NBS (N-bromosuccinimide) oxidation of lactone 2 lead to the
formation of quinone 3. N-hydroxysuccinimide (NHS) was coupled to the carboxylic acid of 3 to
form the NHS-substituted quinone 4 in order to later facilitate the linking of the aminohexanoic
acid chain onto the quinone molecule (Scheme 3.1).
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Scheme 3.1 Synthetic scheme for the NHS-substituted quinone.
The second part of this synthesis was to synthesize the chain structures, because even
though several aminocarboxylic acid molecules with varying sized carbon chains are
commercially available, they cannot be used due to their low solubility in organic solvent. The
following synthetic steps were conducted to develop a tert-butyl protected 6-aminohexanoic acid
chain structure 7 to be added to the quinone moiety. 17
The carboxylic acid group of the starting material CBZ- (carbobenzyloxy) protected 6aminohexanoic acid 5 was protected with a tert-butyl group to yield product 6. The CBZ moiety
was subsequently removed using hydrogen gas and a palladium catalyst to obtain product 7
(Scheme 3.2). This synthetic work was adopted from Lee and coworkers.17
Because NHS is a good leaving group, the chain structure 7 was easily attached to the
synthesized quinone structure 4 to yield product 8. Finally, the tert-butyl protecting group was
removed from 8 using formic acid to achieve the final product 9 (Scheme 3.3).
Products in these synthesis steps were characterized by 1H NMR, GC-MS and ESI-MS.
The purity of products were determined by 1H NMR experiments. Each peak in the 1H NMR
spectra was integrated (solvent peak and TMS peak were not included), and the peaks from the
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product were identified by their chemical shift position. Proton peaks not associated with the
product were also integrated & totaled to account for impurities. The minimum purity of the
product was calculated by the following formula:
Compound minimum purity = (1- Total integrated non-product peak area/Total integrated
product peaks area) ×100% (See Appendix for each calculation).
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Scheme 3.2 Synthetic route for the t-butyl protected 6-aminohexanoic acid (7).
3.2.1

Synthesis of Lactone Product 2
A round bottom flask (RBF) equipped with a stir bar and septum was used for this

reaction. Methanesulfonic acid (10 mL) was put into the RBF and heated to 70 ºC in a mineral
oil bath. Then, 6.6 mmol of the trimethylhydroquinone was added into the RBF, followed by 7.5
mmol of the 3,3-dimethylacrylic acid. After stirring for 2 hours at 70 ºC, distilled water (125 mL)
was added and the dilute solution was then extracted three times with 50 mL of ethylacetate.
The extracts were washed with distilled water, saturated NaHCO3, and NaCl solution, then dried
by MgSO4. The solvent was removed by rotary evaporation. The product was dissolved into a
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CHCl3:hexane (30:70) solvent for recrystallization, and the solvent was finally removed under a
high vacuum. The overall process yielded 45% of the white powder lactone 2. The 1H NMR
spectrum was identical to that reported in literature

7

and was 99.1% pure based on the NMR

integrated peak intensity calculation (Appendix 1.1). GC-MS showed one dominant peak with a
molecule weight of 234 g/mol (Figure 3.3), which corresponds to the lactone product.
1

H NMR (300 MHz, CDCl3) δ ppm: 2.55 (s, 2H), 2.36 (s, 3H), 2.22(s, 3H), 2.18(s, 3H),

1.54(s, 3H), 1.45 (s, 3H)

O

O

OH

Spectrum 3.1 1H NMR spectrum of product 2.

Figure 3.3 GC-MS of product 2.
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Scheme 3.3 Synthetic route for the amphiphilic molecule Q9 with the quinone stimuliresponsive group.
3.2.2 Synthesis of Quinone Acid 3
NBS was recrystallized three times from water. Lactone 2 (21 mmol) was dissolved in
247 mL of CH3CN:H2O (1:9) in a 1.0 L RBF. NBS (22.2 mmol) was dissolved in 49.5 mL
acetonitrile and added to the RBF dropwise with constant stirring at room temperature (RT).
After two hours, the contents were extracted three times with 150 mL of ether, followed by
washing three times with both pure water and NaCl solution. The ether was then removed by
rotary evaporation. The product was recrystallized from hexane and acetone. White cubeshaped crystals were obtained in 85% yield. The structure was confirmed by 1H NMR which
agreed with the published data.18 The purity of product 3 was calculated and found to be 98.8%
(Appendix 1.2).
1

H NMR (300 MHz, CDCl3) δ ppm: 3.03 (s, 3H), 2.15 (s, 2H), 1.95 (s, 3H), 1.93 (s, 3H),

1.44 (s, 6H)
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ESI-MS m/z caculated for C14H17O4 [M-H]- = 248.1127. Found 249.1130 [M-H]- with
δ=1.2 ppm.
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Spectrum 3.2 1H NMR spectrum of quinone acid 3.
3.2.3

Synthesis and Separation of NHS Substitute Quinone 4
Quinone acid 3 (16 mmol) and 17 mmol of N-hydroxysuccinimide (NHS) were added to

a RBF kept at 0 ºC. The mixture was stirred at 0 ºC, and 125 mL of THF was added. DCC (19
mmol) was added slowly into the solution to avoid increasing the temperature, and then the RBF
was removed from the ice bath and reacted at room temperature for 20 hours. The solution was
filtered to remove any solid powder and dried using rotary evaporation to remove THF. DCM
(100 mL) was used twice to strip off THF during this process. The product obtained was
dissolved in 10 mL DCM, then passed through a silica column, which has been flushed prior
with DCM to remove any air bubbles. A mixture of solvent composed of DCM, hexane, and
ether acetate was used to flush the column. The product obtained was confirmed by the thin
layer chromatography (TLC). The solvent was removed by rotary evaporation and kept under
high vacuum overnight. The product 4 was obtained in 75% yield. The chemical shifts of the 1H
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NMR spectrum matched the literature values,11 and the purity of product 4 was calculated to be
95.1% (Appendix 1.3).
1

H NMR (300 MHz, CDCl3) δ ppm: 3.28 (s, 2H), 2.79 (s, 4H), 2.17 (s, 3H), 1.96 (s, 3H),

1.53 (s, 6H)

Spectrum 3.3 1H NMR spectrum of the NHS substitute structure 4.
3.2.4

Synthesis of tert-butyl 6-(benzyloxycarbonylamino) Hexanoate 6
N-benzyloxycarbonyl-6-aminohexanoic acid 5 was purchased from Novabiochem and

used without further purification. Ten mmol of 5 was dissolved in 30 mL DCM and introduced
into a pressure-resistant bottle, which was cooled in a dry ice and acetone mixture. Isobutylene
(40 mmol) was cooled into a liquid state and poured into the bottle. The contents in the bottle
were stirred using a stirring bar. To this, 96% sulfuric acid (0.2 mL) was added, and the
pressure-resistant bottle was sealed and placed at room temperature for 48 hours. After the
reaction was stopped, a NaHCO3 solution (150 mL) was used to neutralize the reaction and the
organic phase was collected and washed with NaCl solution and distilled water three times.
MgSO4 was added to dry the organic phase, it was then filtered, and the solvent was removed
under vacuum resulting in an oil-like product in 85% yield.

1

H NMR data confirmed product

formation and GC-MS was used to analyze product 6, which showed a dominant peak whose
molecule weight of 321 g/mol corresponded to the product. A comparison of 1H NMR spectra of
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product 6 and reactant 5 showed a tert-butyl group attached to the carboxylic acid side
(Spectrum 3.4). The purity of product 6 was calculated and found to be 98.6% (Appendix 1.4).
1

H NMR (300 MHz, CDCl3) δ ppm: 7.40 (m, 5H), 5.13(s, 2H), 3.25 (m, 2H), 2.39 (m,

2H), 1.69 (m, 2H), 1.59 (m, 2H), 1.43 (m, 2H)
3.2.5

Synthesis of t-butyl Protected 6-aminohexanoic Acid 7
Tert-butyl 6-(benzyloxycarbonylamino) hexanoate 6 (6.8 mmol) was dissolved in 10 mL

of ethanol, and 10% palladium on carbon catalyst was added to the solution. The solution was
stirred under hydrogen atmosphere for 48 hours at ambient pressure. The catalyst was removed
by filitration. Ethanol was removed by rotary evaporation and ethyl acetate (10 mL) was added
three times to completely remove the solvent. Finally, the product was put under high vacuum
overnight to obtain an oily product in 90% yield. GC-MS analysis was used for the
characterization of 7. The molecular weight of compound 7 is 187 g/mol. GC-MS data showed
one major peak with an integrated ratio > 90% of this molecular weight.

1

H NMR data also

confirmed formation of 7. The reactant 6 and product 7 1H NMR spectra were compared in
Spectrum 3.5, which clearly shows that the CBZ group has been removed after H2/Pd treatment.
The product 7 was determined to be 98.3% pure (Appendix 1.5).
1

H NMR (300 MHz, CDCl3) δ ppm: 1.36 (m, 2H), 1.44 (s, 9H), 1.4-1.5 (m, 2H), 1.60 (m,

2H), 1.65 (s, 2H), 2.21 (t, 2H), 2.67 (t, 2H)
3.2.6

Synthesis of Molecule 8
NHS-substituted quinone 4 (1.4 mmol) was dissolved in 20 mL of DCM in a RBF, 1.4

mmol t-butyl protected 6-aminohexanoic acid 7 was then added to the above solution with
stirring. TEA (1.5 equivalents) was injected into the RBF while purging with nitrogen. The
reaction was stirred for 24 hours at room temperature, after which, the solution was washed three
times using saturated NaHCO3 aqueous solution, and followed by nano-pure water two times.
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The organic phase was collected and dried using MgSO4. After filtering, DCM was removed by
rotary evaporation. The light yellow cube-like crystals were obtained, and a chromatography
column was used to purify the product. Yellow plate-shaped crystals were obtained in 95% yield,
and 1H NMR confirmed the structure.

The purity of product 8 was found to be 99.5%

(Appendix 1.6). It was shown in Spectrum 3.6 the overlay of 3 and 7 will be similar to 8.
1

H NMR (300 MHz, CDCl3) δ ppm: 5.50 (s, 1H), 3.18 (m, 2H), 2.82 (s, 2H), 2.25 (m,

2H), 2.16 (s, 3H), 1.99 (m, 3H), 1.60 (s, 9H), 1.57 (s, 6H), 1.48 (m, 2H), 1.32 (m, 2H)
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Spectrum 3.4 Comparison of 1H NMR spectra of reactant 5 and product 6.
3.2.7 Removal of the Protecting Group in Compound 8 to Achieve the Final Product 9
Compound 8 (50 mg) was dissolved in 20 mL of formic acid in a RBF and the bottle was
sealed and magnetically stirred for 2 hours. Upon completion of the reaction, formic acid was
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removed by rotary evaporation. Ethyl acetate (10 mL) was used three times to remove the
formic acid completely.
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363.4 363.8 364.2 364.6 365.0 365.4 365.8 366.2 366.6 367.0

m/z
Figure 3.4 High resolution ESI-MS of product Q9.
1

H NMR confirmed the formation of compound 9 (Spectrum 3.8). By comparing the 1H

NMR spectrum of the target compound 9 with that of the starting material 8, it clearly showed
that the t-butyl group had been removed. The 95% yield was achieved for this reaction. The
purity of product 9 was calculated to be 98.9% (Appendix 1.7).
1

H NMR (300 MHz, CDCl3) δ ppm: 5.50 (s, 1H), 3.18 (m, 2H), 2.82 (s, 2H), 2.25 (m,

2H), 2.16 (s, 3H), 1.99 (m, 3H), 1.57 (s, 6H), 1.48 (m, 2H), 1.32 (m, 2H)
ESI-MS (Figure 3.4): m/z found for 9 is 364.2113, with δ=-1.5096 ppm.
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(a)

(b)
Spectrum 3.6 (a) Proton-labeled molecule 7, 3 and 8 (b) Comparison of 1H NMR spectra of
product 8, 3 and 7.
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Spectrum 3.7 Labeled 1H NMR of final product 9.
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CHAPTER 4. PROPERTIES OF THE NOVEL SURFACTANT Q9
4.1

The pH Sensitivity of Q9 Molecule
Previous studies have confirmed that the formation of fatty acid surfactant vesicles is pH

sensitive.1-3 An intermediate pH range was found to be suitable for the development of these
types of vesicles, which usually ranged from 7.0 to 9.0. Because of the similarity in the
molecular structure of the Q9 surfactant and fatty acids, this pH range was expected to apply for
successful Q9 vesicle formation. However, it is important to note that quinones have been
shown to be affected by extreme pH values, particularly at high pH (pH>10).4-6 Thus, it was
necessary to explore the stability of Q9 at various pH values.
For the purpose of studying stability, Q9 solutions were prepared in phosphate buffered
saline solutions (PBS, 0.1 M) with a pH value that ranged from 7 to 11. The solution color
changed from yellow to red when the pH was raised above 10.5, which indicated that the Q9
molecule underwent some changes in the strong base environment. Q9 was stable at pH values
between 7.0 and 9.0 for long periods of time (on the order of a week), as noted by the persistent
yellow color.
The Q9 samples prepared in vary basic (pH = 11 and 14) and the intermediate pH values
were analyzed by UV-vis spectroscopy. The experimental results are displayed in Figure 4.1.
There are significant differences in the UV-vis absorbance signals of the samples. The Q9
samples prepared at pH 7.0 and at pH 10.2 in PBS possess one major peak around 267 nm,
which is typical of quinone molecule in aqueous solution. However, the Q9 sample prepared in
pH 11 PBS has a measurable difference, with a new “broad” peak around 470 nm. This
absorbance peak can also be found when strongly basic conditions (pH 14) were used,
confirming that high pH values result in appearance of this peak. These differences indicate that
some structures changes occur when Q9 was dissolved in a strong base solution. The detail of
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the Q9 structural change under the different pH environment is not related to this study, but it is
assumed that the quinone moiety is decomposed similarly to other quinones. However, the UVvis studies showed that the Q9 structure is unaffected under weakly basic environments (7 < pH
< 10) for periods of up to seven days.

Figure 4.1 UV-vis spectra of Q9 samples prepared in 0.1M pH 7.0 PBS, 0.1M pH 10.2
PBS, 0.1 M pH 11 PBS, 0.1 M pH 14 NaOH and PBS solution.
1

H NMR experiments were conducted on Q9 samples which were prepared at different

pH values. It was discovered that the Q9 samples prepared in the pH range of 7.0 to 9.0 retained
their characteristic spectra features, as noted by comparing the NMR spectra of Q9 in CDCl3
with those in Figure 4.2. The stability of Q9 at pH ≤ 10.5 was found up to 72 hours after sample
preparation.
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(a)

(b)
Figure 4.2 1H NMR spectra (300 MHz) of 8 mM Q9 in pD 8.0 D2O (NaD2PO4) immediately
(a) and 72 hours (b) after sample preparations.
Because of the observed stability of the Q9 structure between 7.0≤pH≤10.5 and the
known ability of n-alkanoic acids to form vesicles under such solution conditions, pH 7.8 PBS
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was selected as the solution in which Q9 properties were to be examined unless otherwise stated.
It was assumed that at pH 7.8 solution conditions would lead to roughly equal amounts of
deprotonated and protonated carboxylic acid groups in Q9.1, 3
4.2

Redox Stimuli-responsive Property of Q9
The purpose of this project was to use a novel surfactant Q9, which was possible be

controlled by redox stimulation, to develop new redox stimuli-responsive vesicles. In previous
synthetic steps, Q9 was synthesized successfully with the designed structure (Chapter 3). In the
following studies, the potential redox stimuli-responsive mechanism and the surfactant
aggregation properties of Q9 will be examined.
4.2.1 Confirmation of the Cleavage of Q9 Structure Upon Redox Stimulation
Q9 possesses a tri-methyl lock quinone moiety, which should be easily reduced by a
chemical reducing agent.7, 8 The reduction product, a hydroquinone, has the potential to undergo
a spontaneously intramolecular cyclization/elimination reaction.

This lactonization reaction

should result in the cleavage elimination of the amino-carboxylic acid backbone of Q9, as well as
the loss of its amphiphilic property for aggregation. This is outlined in Figure 4.3.
Sodium dithionite, Na2S2O4, has been used as an efficient reducing agent in many redox
reaction studies in aqueous environment, including tri-methyl lock molecules similar in structure
to Q9.9, 10 Thus, I have chosen it as the reducing agent to trigger the reduction reaction and drive
the cyclization/elimination lactonization of the Q9 molecule.
1

H NMR analysis was used to probe solutions of Q9 exposed to S2O42-. Upon S2O42-

addition, the quinone of Q9 should be converted to the hydroquinone to allow for the
cyclization/elimination process. Two fragment products should be generated: one being the
hydroquinone lactone product, and the other being 6-aminohexanoic acid from the Q9 chain.
The lactone is known to be insoluble in water and will form a precipitate. It was found that
53

proton signal of the lactone was not detected by 1H NMR upon completion of the reaction,
consistent with its insolubility (Figure 4.5). However, the 6-aminohexanoic acid remained
soluble, and it was stable in the aqueous phase as noted by the proton signals of 6aminohexanoic acid after the reduction reaction. Compared to the stable 1H NMR signal of the
6-aminohexanoic acid chain, the decreasing 1H NMR signal of the quinone moiety can be used
as an index to monitor the cleavage process of the Q9 molecule.
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Figure 4.3 Proposed cleavage of Q9 structure triggered by reducing agent.
Two protons, denoted as e and a (Figure 4.4), were chosen for monitoring the progress of
the Q9 destruction process. Proton e belongs to the quinone moiety, and due to the insoluble
lactone structure, its intensity should decrease with time as is observed in Figure 4.5. Proton a
belongs to the chain structure and is presented in both the
6-aminohexanoic acid molecule product after the Q9 cleavage and in the original Q9 molecule.
The intensity of the 1H NMR signal of a will remain unchanged during the reaction process.
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Figure 4.4 Location of proton e and a in the reactant and products.
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1

H NMR experiments were set up to observe the intramolecular cyclization/elimination

process. Q9 (2 mM) was dissolved at pD 7.8 D2O and placed in the NMR tube. Five equivalents
of Na2S2O4 were added to this tube to trigger the reduction reaction and the corresponding
lactonization reaction. The first 1H NMR acquisition was run 3 minutes after addition of
Na2S2O4. The second one was run 300 minutes later. Experiment results are shown in Figure 4.5.
Signal a maintained the same peak intensity after the Na2S2O4 addition for the entire time
of the experiment (300 mins). Proton signal e was observed 3 mins after addition of Na2S2O4,
but peak e is virtually undetectable after 300 minutes. Three minutes later after the addition of
Na2S2O4, the reduction reaction occurred and the hydroquinone formed from this reduction. At
that moment, the intramolecular cyclization/elimination lactonization reaction had not reached
completion, and the hydroquinone was still dissolved in solution, proven by the observation of
peak e in Figure 4.5. During the 300 minute experiment, which was counted from the addition of
sodium dithionite, the intramolecular cyclization/elimination lactonization reaction went to
completion. The lactone product precipitated from the solution, resulting in the proton e signal
disappearance from the spectra. These results confirm that the desired Q9 redox response can be
achieved in aqueous media with Na2S2O4.
There is one thing that needs to be pointed out: not only do proton e and a experienced
these changes, but the intensities of all proton signals from the quinone moiety decreased to
almost zero after 300 mins, while all proton signals from the aminohexanoic acid moiety in Q9
remained stable during this time period.
4.2.2

Kinetic Study of Lactonization Reaction
The redox-responsive mechanism was confirmed by using 1H NMR to monitor the

selected proton signals. Using the same strategy, the kinetic process of the lactonization reaction
was studied by 1H NMR experiments.
55

300 minutes after the
Na2S2O4 addition

a

3 minutes after the Na2S2O4
addition

e
a

Figure 4.5 1H NMR spectra after Na2S2O4 addition at 3 and 300 mins.
The intensity changes of proton signals e and a were selected again as the index for the
lactonization reaction (Figure 4.6). As shown in section 4.2.1, when Q9 is reduced to the
corresponding hydroquinone structure, the tri-methyl lock mechanism causes the lactonization
reaction. The lactone product precipitates from solution, resulting in the decrease of proton e
intensity, which can be used to determine the rate of the lactonization reaction.
In order to study the kinetic process of the lactonization reaction, twenty three individual
1

H NMR experiments were acquired over a 300 mins time period after the addition of the

reducing agent (Na2S2O4). Each experiment was undertaken with a time gap scaled from 21 to
32 mins. After the experiments, each of the 23 spectra was integrated to calculate the relative
area of peak e and a (Table 4.1). The relative area of peak a (from aminohexanoic acid chain
structure) was used as the standard to normalize the corresponding relative area of peak e in each
spectrum because its intensity is stable. The natural log of the relative area ratio, Ie(t)/Ie(t=0), was
plotted versus time. The results are shown in Figure 4.7.
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(ppm)
Figure 4.6 Spectrum of Q9 and 1H NMR assignments.
A linear relationship (correlation coefficient r=0.997) was observed between ln(Ie(t)/I(t=0))
and the experimental time. This linear relationship can be explained by the mathematical
equation:
⎛I ⎞
⎛M ⎞
ln⎜⎜ e ⎟⎟ ~ ln⎜ e (t ) ⎟ = -kt
⎜ I( ) ⎟
⎝ M0 ⎠
⎝ t =0 ⎠
with Ie(t) being the relative peak area of peak e at time t; I(t=0) being the relative peak area of peak
e before the redox reaction; Me the concentration of the product; M0 the initial concentration of
Q9.
The above equation is the integrated rate law for a first-order reaction based on chemical
reaction kinetic theory. The rate constant can be calculated from the slope of the line: k = - 0.01
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min-1. From the first-order reaction law, the half-life time of the reaction can be calculated as
follows:
ln (0.500) = - kt1/2
t1/2 = ln (0.500) / -k
t1/2 = 69.3 min
Table 4.1 Integrated 1H NMR signals for peak e and peak a of Q9 as a function of time
after addition of Na2S2O4 to 5 mM Q9 in pD 7.8 D2O.

Ia

Ie

Ie(normalized)

Ie(t)/Ie(t=0)

ln(Ie(t)/Ie(t=0))

Time(mins)

1.000

0.960

0.960

1.000

0.000

0.000

0.983

0.760

0.773

0.805

-0.217

22.000

0.982

0.604

0.615

0.641

-0.445

43.000

0.968

0.471

0.487

0.507

-0.680

64.000

0.955

0.368

0.385

0.401

-0.913

85.000

0.960

0.281

0.293

0.305

-1.188

111.000

0.972

0.219

0.225

0.235

-1.450

138.000

0.963

0.161

0.167

0.174

-1.748

164.000

0.977

0.127

0.130

0.135

-2.000

195.000

0.971

0.098

0.101

0.105

-2.256

227.000

0.952

0.069

0.073

0.076

-2.584

258.000

0.969

0.059

0.061

0.064

-2.755

290.000
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Figure 4.7 NMR kinetic experiments from 5 mM Q9 in pD 7.8 D2O exposed to solid sodium
dithionite.
Compared with other known tri-methyl lock quinone redox systems,8 this half-life time is
suitable for the application. As shown in Figure 4.2, there are two reactions that occur after the
addition of Na2S2O4. The first reaction is the formation of hydroquinone upon the reduction of
Q9, which occurs virtually instantaneously as noted from UV-vis experiments on Q9 with added
Na2S2O4 in Figure 4.8 (ten seconds were the minimum time for conducting the UV-vis
experiment after Na2S2O4 addition). This can also be easily observed by eye, as the quinone
form of Q9 is yellow, and the hydroquinone is colorless. The fast speed of this reaction and the
virtually identical 1H NMR spectrum of the hydroquinone of Q9 makes it ignored to follow this
reaction by NMR.
4.3

Critical Aggregation Concentration Study
From a structural point-of-view, Q9 should possess the properties of a typical

amphiphilic molecule that has the ability to aggregate in aqueous phase if its concentration is
high enough. To enable the formation of Q9 vesicles, it is important to find out at what
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concentration Q9 begins to form aggregates. There are different methods that can be employed
to determine the critical aggregation concentration (CAC) as noted by numerous previous
studies. In this study, tensiometry was selected for this purpose.11 The experimental details were
described in Chapter 2. In Figure 4.9, the CAC of Q9 was obtained from the surface tension
detection method in pH 7.8 PBS (40 mM).

Figure 4.8 UV-vis absorbance change after Na2S2O4 addition of Q9 pH 7.8 PBS solution
To compare these results, surface tension measurements were conducted on
6-aminohexanoic acid, NH2(CH2)5COOH, that under same solution conditions as Q9 in Figure
4.9. Experiment results are plotted in Figure 4.10.
Q9 surface tension experimental results (Figure 4.9) were a good match with surfactant
aggregation theory. Two linear relationships were found from the experimental data. In the low
concentration range (from 0 to 7 mM), there was a decline that represented the surface tension
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was decreasing with increasing Q9 concentration. However, in the high concentration range (>
roughly 7mM), another linear relationship was observed. The slope was significantly less,
presumably because no more Q9 molecules could insert into the monolayer at the air-water
interface. It is unclear at this time why the slope of the line is not zero at Q9 concentration above
~7 mM; however, this is typical of many types of surfactants. The intersection point of these
two lines is the turn over point where Q9 aggregates are formed, with the concentration at this
point being the CAC of Q9. Thus, the determination of the CAC can be found by setting the two
linear equations equal to each other and solving for concentration, yielding a value of 7.1 mM.
Surface Tension Experiment of Q9
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Figure 4.9 Surface tension measurements of Q9 in 40 mM pH 7.8 PBS solution as a
function of Q9 concentration.
As we look at the surface tension experiment of the 6-aminohexanoic acid (Figure 4.10),
there is no change in the surface tension as its concentration was increased. The surface tension
was found to vary between 74 mN/m and 76 mN/m even though the concentration was increased
above 50 mM. Based on these results, 6-aminohexanoic acid is not an amphiphilic (surfactant)
species, and it can not concentrate at the water-air interface when it is dissolved in aqueous
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solution. Thus, the surface tension will not be significantly affected upon the addition of the
compound to aqueous solutions.

Surface Tension Experiment of 6 Aminohexanoic Acid
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Figure 4.10 Surface tension measurements on 6-aminohexanoic acid in 40 mM pH 7.8 PBS
solution.
The different surface tension experimental results between 6-aminohexanoic acid
molecule and Q9 confirmed the amphiphilic property of Q9. Meanwhile, based on previous
studies, 6-aminohexanoic acid was the only water-soluble structure present after the
intramolecular ring cyclization reaction of Q9. The surface tension property of this compound
indicated that no aggregates will be formed after the redox reaction has reached completion at its
concentration used (maximum concentration of 6-aminohexanoic acid would be ~ 10 mM).
Micelles and planar bilayer aggregates can both be formed in solution from n-alkanoic
acid. It is difficult to determine what type of aggregate was formed from Q9 at this point, but
previous studies indicated that the single-chain surfactant vesicle formation concentration is
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much lower than the critical micelles concentration.2, 3 Thus, a Q9 solution with a concentration
prepared above the CAC concentration should be sufficient for the vesicle formation.
4.4
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CHAPTER 5. Q9 VESICLE FORMATION AND CHARACTERIZATION
5.1

Formation of Q9 Vesicles by Extrusion Treatment
Q9 vesicles were formed by the extrusion technique, which has been extensively

employed for phospholipid vesicle formation.1

This operation utilizes a device called an

extruder to generate a strong shear force on the surfactant molecule, when they are pushed
through a membrane that is located inside the extruder. The shear force has been proposed to
help cause surfactants to form vesicles. Although the mechanistic details of vesicle formation
during the extrusion event is still under investigation, the practice of this method has confirmed
its efficacy for vesicle formation.1-3
Four steps were employed for Q9 vesicle formation using this method: (1) 3 mg of Q9
was dissolved in 5 mL DCM in a round bottom flask and dried by rotatory evaporation to form a
thin layer film. Then it was placed under high vacuum for 2 hours to remove any DCM left
inside the flask; (2) 0.7 mL PBS solution (pH 7.8, 50 mM with 50 mM NaCl) was added into the
flask to hydrate Q9 for 1 hour; (3) After vortexing for 15 minutes, the Q9 solution then
underwent a freeze-thaw process 7 cycles by using a dry ice/acetone and a warm-water bath; (4)
The liquid was then extruded through a hand- held extrusion device (Avanti Polar Lipids,
Alabaster, AL) with 100-nm pore diameter polycarbonate membrane (Whatman, Maidstone,
UK). The extrusion process was repeated 20.5 times. Then the solution was transferred into a
clean glass container and stored until needed in dark under N2.
5.2

TEM Experiments on Q9 Vesicles With Stained Materials
TEM experiments were employed to study the formation of Q9 vesicles. The Q9 sample

was deposited onto a carbon-coated copper grid. The negative stain method was used to stain the
sample with 2% uranyl acetate. This method has been used for the study of phospholipid vesicle
formation.4, 5 The experimental results are shown in Figure 5.1.
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Figure 5.1 Representative TEM experimental results for Q9 vesicles stained with 2%
uranyl acetate
These preliminary TEM results indicated that aggregates of Q9 exist in solutions
prepared as described here. Vesicles and micelles were two possible aggregates6 for these
spherical-like structures which were observed in the TEM experiment. The diameter of these
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imaged structures ranged from 20 nm to 160 nm in the samples, with an average size distributed
around 80 nm. As shown in previous work with n-alkanoic acid, micelles with diameters smaller
than 10 nm have been observed for solution pH values of 8.5 to 12.7 Larger micelle aggregates
have been reported, but generally these structures were resulted from the surfactants that
contained high molecular weight polymer
chains.8, 9 The edge area on the captured spherical aggregates in the TEM image was identical to
a round spherical structure, which is the typical vesicle aggregate structure.

Thus, it is

reasonable to conclude the aggregate structures observed in these TEM images are vesicles of Q9.
5.3

Light Scattering Measurement on Q9 Vesicles Sample
Light scattering techniques have been widely used for the characterization of particles in

solution.10 Two different light scattering techniques were used to characterize the Q9 vesicles:
static light scattering (SLS) to determine the radius of gyration (Rg), and dynamic light scattering
(DLS) to determine the hydrodynamic radius (Rh).
5.3.1

Light Scattering Experiments on a Home-Built Instrument
Q9 vesicle samples prepared in variety PBS solutions (50 mM with 50 mM NaCl) were

investigated by both SLS and DLS measurement. The light scattering instrument is a home-built
machine in Dr. Russo’s lab in the Department of Chemistry at LSU. The experimental results
are listed in the following Table 5.1.
Samples 1 and 2 were prepared in pH 8 PBS with different Q9 concentrations. Sample 3
was extruded at pH 10.2 PBS. Sample 4 is Q9 vesicle sample extruded at pH 11.6, then the pH
was adjusted to 6.9.
These results revealed some interesting properties about Q9 vesicles. First of all, the
light scattering experiments demonstrated the presence of aggregates in solution. Samples and
containers had been treated carefully to remove any dust and impurities. Thus, the aggregates
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present can only be generated from the Q9 molecule. Sample 1 failed in the observation of Rg
because of the low quality decay line recorded during the experiment time. The calculation of Rg
is unavailable based on the collected data. This may be caused by the wide distribution of
particle sizes that exist in solution for this particular sample.
Table 5.1 Light scattering experiments on Q9 vesicle PBS solutions (50 mM with 50 mM
NaCl)

Experiment
Number

1

Condition

12 mM Q9,
10 mM Q9, pH 12 mM Q9, pH 12 mM Q9, pH prepared at pH
11.6,
then
10.2
8.0
8.0
adjust to pH 6.9

Rg (SLS)

N/A

112 ± 1 nm

147 ± 1 nm

119 ± 1 nm

Rh (DLS)

140 nm
& 39 nm

132 nm
& 24 nm

71.4 nm

61.6 nm

2

3

4

Different Rh sizes are formed at different pH value. Q9 samples prepared at pH 8.0
(samples 1 and 2) possess an Rh value that is obviously larger than the Rh of Q9 samples prepared
under a higher pH value (samples 3 and 4). Even for sample 4 where the pH had been decreased
to 6.9 after Q9 vesicle formation, the Rh was still much smaller than samples prepared directly at
pH 8. The Rg sizes obtained from SLS (112 nm, 147 nm, 119 nm) do not exhibit this significant
size change in different pH PBS solution. Based on the LS theory, the Rg vs Rh ratio of the
perfect hollow spherical structure equals to 1.0. Except for sample 2 (pH 8), the ratio of Rg vs Rh
in sample 3 and sample 4 are much bigger than 1, which indicates the difference of those
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aggregates from a hollow spherical structure. One possible reason for these results may come
from the different protonation situation of the carboxylic acid group inside the Q9 structures
under different pH. The change of ratio between COOH and COO- groups from Q9 structure
under high pH value would affect the vesicles’ structure.11, 12
Dynamic light scattering has the advantage of measuring smaller sized particles
compared with SLS experiments.10 Each DLS experiment on pH 8.0 samples led to observation
of two different size distributions existing in the samples (i.e. samples 1 and 2): one larger size
(140 nm or 132 nm) and one small size (39 nm or 24 nm). This observation points to a unique
behavior for Q9 in aqueous buffer solutions. Extrusion of phospholipids typically leads to
generation of a narrow-sized distribution of vesicles.13 The presence of two populations of Q9
vesicles may be contributed by the special quinone group in the molecule, as well as the result of
the decreased bilayer stability of Q9 because of its single-chain structure.
5.3.2

Dynamic Light Scattering Experiment on Zetasizer Nano Instrument
The DLS experiments were conducted using a Malvern Zetasizer Nano Instrument

(Malvern, Worcestershire, UK). Two different samples were chosen for this experiment. One
was a traditional phospholipid vesicle, dioleoylphosphatidylcholine (DOPC), in water solution,
which is known to form stable vesicles upon extrusion. The other was Q9 vesicle prepared in pH
7.8 PBS (50 mM) solution under condition identical to sample 2 in Table 5.1. Both samples
were developed through the same procedure obtained in Section 5.1.
DOPC was used as a model lipid compound to generate vesicles.

DOPC vesicle

formation is well documented in previous studies, including those that employ the extrusion
technique.14,

15

Therefore, it was used as a standard for comparison to Q9 vesicles. The

experimental results are shown in Figures 5.2 (DOPC) and 5.3(Q9).
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120 nm

Figure 5.2 DLS experimental results for DOPC vesicle sample (1 mg/mL DOPC in 50 mM
pH 7.8 PBS).
Both DOPC and Q9 samples yielded the particle size distribution peaks based on the
scattering intensity measurement, confirming the formation of aggregates in these samples. The
DOPC data possesses a sharp, narrow peak centered near 120 nm in Figure 5.2. This was in
qualitative agreement with previous reports on DOPC vesicles.1 The Q9 aggregates had a
broader distribution range than DOPC (Figure 5.3). Two peaks were observed for this sample.
The major peak is located at 160 nm (diameter), and there is also a smaller peak intensity
centered at near 40 nm diameter. Because of the overlap of this 40-nm peak with the major peak
at 160 nm, the data appears a shoulder style in the Figure 5.3. Compared to the DOPC sample,
we can conclude that there were two different size distributions in the Q9 samples.
The mechanism of the extrusion process is still under investigation;1 however, it is
believed the pressure generated inside the membrane hole reorganizes the aggregates and helps
form them into spherical vesicles.2 For the work here with DOPC, the membrane pores clearly
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restricted the size of vesicles when they were formed. Q9 is a single-chain surfactant structure
possessing a carboxylic acid group; the stability of the bilayer structures formed from this
molecule are evidently more difficult to control compared with the two tailed phospholipid
DOPC. Thus, a wide distribution of aggregates was generated during the extrusion process.

160 nm

40 nm

Figure 5.3 DLS experimental results for Q9 vesicle sample (12 mM Q9 in 50 mM pH 7.8
PBS).
5.4

CryoEM Experiment on Q9 Vesicles
CryoEM was used to characterize vesicle size and to obtain possible information on

lamellarity of the Q9 structures. As has been previously shown, CryoEM can be used to obtain
the closest version of the solution structure of aggregates.16 The vesicle solution samples were
frozen quickly into a thin ice film on TEM grids. The frozen vesicle sample in this process is
believed to have the least possible distortion and contain the fewest possible artifacts.16 Q9
vesicle samples were prepared through the extrusion technique in pH 7.8 PBS (50 mM) solution
at 12 mM. Representative results are shown in Figure 5.4.
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The CyroEM images not only confirmed the formation of Q9 vesicles upon extrusion of
12 mM Q9 in pH 7.8 PBS, but vesicle’ size information can be obtained. From the images, the
Q9 vesicles possess widely different sizes, ranging from 20 to 150 nm. The concentration of
these vesicle aggregates were not high enough to make them homogeneously observed on the
TEM grid. The dynamic fatty acid vesicle formation model can be utilized to describe Q9
vesicle samples17 (See Figure 1.7 in Chapter 1). The Q9 vesicles may be dynamic balance
system constructed by the small number vesicles surrounded by many Q9 single molecules and
small Q9 micelles, which has been described by other fatty aid aggregates studies.

17

Based on

this theory, it will be difficult to achieve highly concentrated Q9 vesicles in the extruded samples.
5.5 Study of Q9 Vesicle Distribution by Asymmetrical Flow Field-Flow Fractionation
(AF4) Technology
AF4 technology was applied to study the size distribution of extruded Q9.18-20 DOPC
vesicle samples that were made using the same extrusion technique were used as a standard
sample to develop suitable experiment methods for control of the field flow.18

The light

scattering intensity was used to monitor the eluted samples. After the experiment, Rg of the
particles was calculated using the instrument software as a function of elution time.
Experimental results are shown in Figure 5.5 and Figure 5.6.
Comparing the experiment results of 1 mg/mL DOPC sample and 4.5 mg/mL Q9 sample
prepared under the same condition, the recorded light scattering intensity of eluted Q9 aggregates
was less than 2% of the light scattering intensity of eluted DOPC vesicle sample, which indicated
a much lower concentration of Q9 aggregates in the sample. The high CAC value of 7.1 mM (by
surface tension measurement, Chapter 4) would indicate that Q9 does not prefer to exist in the
aggregates. Although the Q9 samples were prepared above its CAC, it was difficult to form a
high concentration of Q9 aggregates. The effort to increase Q9 aggregate number by increasing
Q9 concentration in buffer failed due to reaching the Q9 solubility maximum in the buffer.
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Figure 5.4 Q9 vesicles developed by extrusion treatment with a variety of sizes.
Experiments were conducted under conditions described in Section 2.3.4 in Chapter 2.
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Figure 5.5 Light scattering intensity (recorded at 90o) of 12 mM Q9 sample in pH 7.8 PBS
(50 mM) during the AF4 separation process; peak at 9 min and 70 min are generated by
the flow condition change.

Figure 5.6 Rg size distribution calculated from AF4 experiment on Q9 sample. The data
value changed after 50 minutes due to the change of flow condition.
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Although the concentration was low, AF4 experiments confirmed the existence of Q9
aggregates with different sizes and provided a size distribution (Figure 5.6). In this experiment,
different field-flow conditions were applied to achieve the best separation. Nine minutes after
the sample injection the flow condition was maintained to separate the vesicles with different
sizes. Fifty minutes later, the flow condition was adjusted to flush the larger particles out. A
main elution peak around 47 min can be observed, as well as a small peak around 30 min. The
calculated particle sizes (Rg value) for the corresponding peaks were 110 nm (45 min) and 40 nm
(30 min). Furthermore, there were different sizes that ranged from 20 nm to 220 nm that eluted
at different times. These different-sized aggregates are difficult to be classified as micelles,
because one compound usually only forms one uniform micelle structure in a given solvent
system.21 Vesicle morphology was the suitable model to explain these aggregates type.
5.6

Conclusion from Different Characterization Methods
Through each of the characterization methods, Q9 aggregate formation was confirmed.

Light scattering results from the home-built machine (Russo Lab, Chemistry Department, LSU)
and Zetasizer Nano Instrument (Malvern, Worcestershire, UK) both point to the existence of Q9
aggregates having different sizes. These particles had a wide size distribution that ranged from
20 nm to 200+ nm. Also, DLS data led to observation of two major sizes for these particles.
CryoEM images of Q9 aggregates in buffer solution point to a similar outcome, as different
particle sizes were found and spanned the 20-200 nm range. These aggregates are believed to
best represent the original structures in buffer solution because of the inherent properties of
CryoEM. The typical spherical structure and large size of these Q9 aggregates from these
experiment results confirmed them to be vesicles. From the AF4 separation study, the size
distribution of Q9 vesicles was observed.

These results confirmed the previous DLS and

CryoEM results.
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Although Q9 vesicle formation was confirmed through these characterization methods,
both CryoEM and AF4 separation indicate that the concentration of Q9 vesicles is low in the
aqueous buffer solution used here. One reasonable explanation is coming from the structure of
the single hydrocarbon chain Q9 molecule, which is difficult to get stabilized as those “double
tail” phospholipids, when Q9 vesicles are formed.

The whole solution system may be

constructed by Q9 vesicles surrounded by many Q9 molecules, which was similar to the other
single chain fatty acid vesicle systems.17
5.7
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CHAPTER 6. STUDY OF THE ENCAPSULATION AND CONTROLLABLE
RELEASE PROPERTIES OF Q9 VESICLES
In Chapter 4, sodium dithionite, Na2S2O4, was used to successfully trigger the
lactonization reaction of Q9, and these experimental outcomes point to the distinct possibility
that redox stimulation may allow for control over the confinement of guests within the aqueous
interior of Q9 vesicles. Thus, it is anticipated that the ring cyclization lactonization reaction
should cause the breaking up of Q9 monomers and disassembly of Q9 aggregates.

The

encapsulation and possible controllable release properties of Q9 vesicles will be evaluated in this
Chapter.
6.1

DLS Experiments on Q9 Vesicles
A Nano-Zeta DLS instrument (Malvern, Worcestershire, UK) was utilized for this

research. Q9 vesicle samples were prepared via the extrusion technique as outlined in Chapter 5.
The Q9 solutions prior to extrusion were made at 12 mM Q9 concentration in 50 mM pH 7.8
PBS solution. Two Q9 vesicle solutions were placed in the DLS sample cells, sample 1 and
sample 2. Sample 1 was used as the Q9 vesicle background. Solid Na2S2O4 40 mg (10
equivalents) was added to sample 2 and mixed for 5 minutes. Then DLS was performed on both
samples. Results are shown in the Figure 6.1.
Clearly, the addition of Na2S2O4 changed the nature of the Q9 vesicles in solution. The
original Q9 aggregate peak was diminished after the treatment, leaving a broad peak with low
intensity containing some quite large particles (> 200 nm). This indicated that most of the
original Q9 vesicles were spontaneously altered (much smaller size) by the reduction reaction.
DLS is based on the measurement of particle diffusion coefficient (D), which makes it sensitive
for the detection of small particles due to their higher D value.1 Two products are formed from
the Q9 reduction reaction: the hydroquinone lactone and the 6-aminohexanoic acid (Chapter 4).
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It would appear that lactone particles formed in the solution precipitated out with a random size
distribution, caused a broad DLS peak with low intensity to be observed (d>200 nm).

(a)

(b)
Figure 6.1 DLS experiment on the redox-stimulation results (a) 12 mM Q9 vesicle sample
in 50 mM pH 7.8 PBS (b) 12 mM Q9 vesicle sample in 50 mM pH 7.8 PBS after Na2S2O4
treatment.
Filtered (membrane pore size 100 nm) 12 mM 6-aminohexanoic acid buffer solutions
were examined under the same LS experiment setup, which theoretically should have no
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particles present, due to its good solubility in water. However, there were always non-repeatable
peaks showing up in the experiment results, which indicated the peaks shown in those results can
not represent the real particles inside the solution. Those peaks were similar to the peak around 1
nm in the previously sample 2 experiment (Figure 6.1b) in Q9 vesicle reduction. Based on this
control experiment, the small particle peak (around 1 nm) in Figure 6.1b is considered an artifact
in the results, and most likely resulted from software limitations.
DLS experiments were also conducted to monitor the change of particle’s sizes of 12 mM
Q9 vesicle sample after the reduction reaction triggered. Experiment was set up as the same as
those described in the first paragraph of 6.1. Each experiment was run every one minute after the
addition of 10 equivalents of Na2S2O4 (beginning at 3 minute). The results are shown in Figure
6.2.

Figure 6.2 Particle’s sizes of 12 mM Q9 vesicle sample in 50 mM PBS monitored by DLS
after Na2S2O4 addition.
The initial Q9 vesicle possesses a diameter of 140 nm in this sample. After the reducing
agent addition, the particle size increased dramatically with a random size distribution, which
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indicated the formation of lactone solid particles upon the reduction reaction. About thirty
minutes later, the particle size began to decrease into the size range below 1000 nm, which can
be explained by the precipitation of lactone particles onto the bottom of solution.
6.2

Encapsulation of Water-Soluble Calcein Dye in Q9 Vesicles
The encapsulation characteristics of Q9 vesicles and their reduction induced release

properties were investigated using calcein dye, and were followed with fluorescence intensity
measurements. Calcein is widely used as an encapsulation agent in vesicle-related studies.2-4
Upon excitation at 495 nm, a strong emission is monitoring at 510 nm for dilute solution of
calcein. The self-quenching property of calcein has been reported in previous work,5 with
efficient self-quenching occurring when calcein concentrations were higher than 10 mM, leading
to a significant loss in fluorescence intensity with increased calcein concentration.5 Thus, the
difference in fluorescence intensity between quenched and free calcein can be used to monitor its
encapsulation and release status in vesicle encapsulation studies. This effect can also be watched
by eye, as different colors were observed for different concentrations of calcein, with
concentrated self-quenching calcein solutions being red in color, low concentration nonquenching samples being green. This color difference was utilized to facilitate the collection of
size-exclusion separation of vesicles.
Based on self-quenching property of calcein, highly concentrated calcein (50 mM)
solution were prepared in PBS solution (100 mM with 100 mM NaCl, pH 7.8). Q9 (12 mM) was
dissolved in this concentrated calcein solution, then the solution was extruded as the same Q9
vesicles preparation method as those described in Chapter 5. Thus, calcein was encapsulated
during the Q9 vesicle formation. Free calcein molecules left in solution were removed by sizeexclusion chromatography as described below.
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The characteristic of preparative size-exclusion chromatography were described in
Chapter 2.6 When calcein was encapsulated inside the vesicles, the initial concentration of 50
mM will be well maintained upon vesicle dilution/separation due to the protective of the vesicles
nature. Thus, the calcein inside the vesicle will stay self-quenched during the chromatography
process and will be red in color. However, free calcein in solution will be diluted to be lower
than the self-quenching concentration during the separation process and will be green in color.
Red Q9 vesicles containing calcein will move faster in the column based on the principle of sizeexclusion chromatography. Thus, different colors should be observed in different parts of the
column, as schematically shown in Figure 6.3, if the calcein has been encapsulated successfully.
Experimental results were identical to that predicted above. The observed red color at the
leading edge of the separation can be explained only by the presence of encapsulated, selfquenching calcein in the Q9 vesicles.

This result confirmed Q9 vesicles can be used to

encapsulate water-soluble agents over the time scale of the separation process (60 min). The red
band was collected and the green aliquot was discarded. The calcein containing vesicles were
passed through another column to ensure all the free dye was removed. Finally a UV-vis
experiment was carried out on this sample to measure the absorbance intensity. The UV-vis
experiment result was compared with the UV-vis experiment of the Q9 molecule absorbance
intensity in the same buffer solution in the Figure 6.4.
The recorded UV-vis absorbance peak for the column separated sample was located
around 490 nm, which was identical to the calcein absorbance wavelength (Figure 6.4). The
pure Q9 molecule UV-vis absorbance intensity measurement in the same buffer solution shows
no peak at 490 nm (Figure 6.4). The sample was collected to exclude free dye, therefore, only
big particles should be present in the sample. The presence of small calcein molecule in this
sample indicated that calcein was encapsulated inside the Q9 vesicles.
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Polymer Bead

Solvent Flow

Injected with
mixed size

(a)

(b)
Green color moves slowly:
Diluted free calcein below the
self-quenching concentration

Red color moves fast:
Vesicles containing selfquenching calcein

Figure 6.3 Illustration of the color change during the preparative size-exclusion
chromatography separation. (a) mixed free calcein and vesicle samples with self-quenching
concentration; (b) particles separated based on size. Q9 vesicles (large) containing calcein
move faster through the column and diluted free calcein (small) moves slower.

Figure 6.4 UV-vis absorbance experiment on the preparative size-exclusion
chromatography separated Q9 vesicle sample with calcein encapsulated; and UV-vis
absorbance experiment on 1 mM Q9 molecule in 100 mM pH 7.8 PBS.
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6.3

Study of the Controllable Release Property of Q9 Vesicles
Q9 vesicles containing calcein from Section 6.2 were separated and collected in the

buffer solution. This sample was used to study the controlled release of dye from Q9 vesicles
triggered by Na2S2O4 reducing agent.
pH 7.8 PBS solution (100 mM with 100 mM NaCl,) was used to dilute the separated
vesicle sample until the UV-vis absorbance intensity was within the range of 0.05 – 0.1. This
intensity range will allow the fluorescence study to be conducted within the instrument detection
limits.
The diluted Q9 sample was placed in the fluorescence sample cuvette and then put into
the luminescence spectrometer (Perkin Elmer, LS50B, Waltham, MA). A kinetic fluorescence
mode was applied for this study. Every 5 minutes a fluorescence intensity measurement was
obtained on the sample using an excitation wavelength of 495 nm and an emission wavelength of
510 nm. After a stable background was achieved, Na2S2O4 was added into the sample, and
intensity measurements were recorded every 5 min. The experiment results are shown in Figure
6.5.
The fluorescence signal of column-purified Q9 sample increased after the reducing agent
was added. The intensity changed immediately (47% intensity increase) and kept increasing
(110% intensity increase) in the next 20 hours. This result indicated the encapsulated calcein
was released after the redox-stimulation occurred. The fluorescence signal increased due to loss
of the previous self-quenching state after calcein was released into the buffer solution. This
result confirmed the controllable release of calcein from Q9 vesicles can be achieved by the
redox stimulation.
The increase in calcein intensity was not as large as that found in previous work with
encapsulation of calcein.5,

7, 8

In AF4 experiments, we found the concentration of these
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aggregates (light scattering relative intensity) is obviously smaller than the traditional
phosphilipid based liposome vesicles formed under the same conditions.
confirmed by observations from the CryoEM experiments.

This was also

The decrease in number of

aggregates will dramatically reduce the total volume available for calcein and result in lower
fluorescence intensity than expected. Meanwhile, AF4 experiment results showed small Q9
aggregates are counted more than big ones. The decrease in radius of a spherical structure will
decrease its packing volume on a large scale (V~R3). The more small vesicles present in the
solution, the less the fluorescence intensity would change.

Figure 6.5 Fluorescence intensity increases upon the addition of Na2S2O4 to Q9 vesicle
sample containing calcein.
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CHAPTER 7. SUMMARY OF CONCLUSIONS AND FUTURE STUDIES
7.1

Summary of Conclusions
Novel redox stimuli-responsive surfactant structure was synthesized successfully in seven

steps.

1

H NMR and MS were used to characterize the products. The final product, Q9, was

confirmed by ESI-MS and 1H NMR. A “trimethyl-lock” quinone moiety was utilized in the Q9
to enable the redox-stimuli responsive property. Once the quinone moiety was reduced to the
hydroquinone, a spontaneous intramolecular cyclization/elimination reaction occurred that broke
the Q9 backbone. This redox stimuli-responsive mechanism was confirmed by the 1H NMR
kinetic study by monitoring the protons intensity change on the Q9 structure.
Q9 is a typical amphiphile that can aggregate in an aqueous solution.

A critical

aggregation concentration (CAC) of 7.1 mM for Q9 was obtained using surface tension
measurement at room temperature. Q9 structure is sensitive to the pH of the solution. A UV-vis
study on the Q9 solution samples prepared in different pH buffers found that a new absorbance
peak near 470 nm appeared among the Q9 samples prepared in high pH PBS (pH>11).

1

H NMR

was applied to observe the stability of the Q9 structure while the pH was varied. Experimental
results confirmed that the structure stability of the Q9 was maintained in the intermediate pH
range from 7.0 to 9.0. Previous work found that a roughly equal amounts of protonated and
deprotonated fatty acid group in fatty acid molecules was achieved in this pH range, which was
suggested to be important for the formation of the fatty acid vesicle aggregates. Thus, a pH 7.8
PBS was used as the solvent system to prepare the Q9 vesicles.
The Q9 vesicle formation process was conducted by extrusion, which was used widely to
develop phospholipids vesicles. Q9 PBS solution (12 mM) above the CAC was chosen for the
extrusion to ensure aggregation would occur. After extrusion, CryoEM and Light Scattering (LS)
experiments were used to check the vesicle formation. Both Static Light Scattering (SLS) and
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Dynamic Light Scattering (DLS) confirmed the Q9 vesicle formation in the extruded sample.
DLS also detected that the sample was polydisperse with sizes ranging from 20 nm to 200+ nm.
CryoEM experiments captured the direct image of these spherical Q9 vesicles.

The

concentration of Q9 vesicle was small based on the observation of these CryoEM images.
Asymmetrical flow field-flow fractionation (AF4) was used to study the Q9 aggregates
size distribution. A variety of sizes of Q9 aggregates can be separated from the sample, which
matched with the DLS and CryoEM results. A lower intensity was observed from the scattering
light of Q9 vesicle sample than DOPC vesicle sample. Because AF4 separated the different sizes
of particles, the size effect on the light scattering intensity should be eliminated. Thus, the
observed low intensity of light scattering signal can be inferred that there are less Q9 vesicles
present than the DOPC vesicle sample prepared under same conditions.
Sodium dithionite (Na2S2O4) was used as the reducing agent to trigger the intramolecular
cyclization/elimination reaction, which can break the Q9 monomer. Disassembly of Q9 vesicles
was monitored by DLS. After the addition of 10 equivalents of sodium dithionite, Q9 vesicles
were destroyed based on the DLS experiment observation. This result confirmed Q9 vesicles
can be controlled by the designed redox stimuli-responsive mechanism.
To study the encapsulation and controllable release properties of the Q9 vesicles,
concentrated water soluble dye, calcein (50 mM), was chosen to be entrapped within the Q9
vesicles. The encapsulation was conducted by the mixing of calcein and Q9 molecule together
before extrusion. After extrusion, vesicles containing calcein were separated from the free
calcein by a preparative size-exclusion chromatography. A fluorescence study was conducted on
the Q9 vesicle/calcein sample without the interference from the free calcein molecule. Sodium
dithionite was added into this solution to trigger the release of calcein from the vesicle. The
fluorescence intensity increased after the Na2S2O4 addition, which indicated that the calcein
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molecule was released after the redox-stimulation occurred. The fluorescence signal increased
due to loss of the previous self-quenching state after calcein was released into the buffer solution.
This result confirmed that the Q9 molecules possess the ability to encapsulate a water soluble
agent and to release it under the controllable redox stimulation.
The fluorescence intensity increased in the controllable release experiment was not as
large as that found in previous work with encapsulation of calcein. This could be contributed by
the low concentration of Q9 vesicles which generated by the extrusion method. More studies
were needed to be conducted in the future to improve the capacity ability of Q9 vesicles.
However, the achievements in this study have confirmed Q9 vesicle system can be made by
extrusion, and possesses the ability to encapsulate water soluble compound and release them
under redox stimulation method.
7.2

Future Work
Q9 vesicles possess unique properties. The work presented in this study demonstrated

they

can

be

controlled

by

the

reducing

chemical

agent,

sodium

dithionite.

To adopt the Q9 vesicles into a variety of applications, a more comprehensive study is needed to
explore the properties of Q9 under different environment. Other methods can be utilized to
manipulate Q9, depending on the types of application desired.
One potential application of Q9 vesicles is for the drug delivery system. The toxicology
studies of this molecule should be evaluated. Q9 has low toxicity to human based on the previous
quinone based prodrug research.1-4

It is predicted the Q9 vesicle would meet the clinical

standard when it is applied in vivo environment.
The study in this dissertation exhibited the encapsulation and protecting mechanism of
Q9 vesicles for the water soluble compound, which is crucial for the drug delivery system.
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However, the reduction of the chemical compound sodium dithionite is difficult to apply in this
kind of application. Thus, a new stimuli-responsive mechanism should be used.
It has been confirmed that some reductase enzymes have abnormal strong activities in the
mutated cells.5 For example, DT-diaphorase (NADH:quinone) is an oxidoreductase enzyme
widely exists in the cell membrane that can reduce quinone molecules. Recent study on cancer
cells found DT-diaphorase presented a super high activity compared with other enzymes in
variety of cancer cells. Although the mechanism of this strong enzyme activity is still under
investigation, this property can be used to design the new stimuli-responsive mechanism for the
Q9 vesicle delivery system.
It was proven that the redox reaction of “trimethyl lock” quinone moiety in Q9 structure
will cause the deterioration of Q9 molecule. DT-diaphorase possesses a strong reduction ability
that reduces the quinone molecule in the cell membrane. This strong activity in the mutated cell
will lead to the similar reduction of the Q9 structure. It is reasonable to adopt this ability onto the
Q9 molecule to develop a new controllable release mechanism.
Q9 vesicles containing water-soluble drug (developed by the extrusion technique) should
be mixed with DT-diaphorase in vitro to study the drug release process. The UV-vis detection
method can be applied to monitor the change of the specific UV-vis adsorption peak of drug
molecules during this process. These changes indicate the drug compound can be released upon
the breakage of the Q9 vesicles. Different DT-diaphorase samples with a variety of activities can
be achieved by adjusting the concentration and should be tested to find out the different response
of the Q9 vesicles. Due to the complex environment for the in vivo application, the enzyme
activity will be different from their in vitro behavior. Thus, more studies are needed with a
clinical and pharmaceutical resource.

89

Tm

T0
Figure 7.1 Microfluidic channel with temperature gradient.

Another application of the Q9 vesicle is to use them as the efficient containment and
delivery system in the microfluidic analysis device, which can enable advances in “lab-on-achip” technology. The microdiameter channels inside these microfluidic devices cause the
reagent to flow slowly and mix sluggishly compared to the regular flow condition. Locascio and
Vreeland, who specialize in this area at the National Institute of Standards and Technology
(NIST), suggest that high efficiency mixing and reagent delivery is “fundamental important for
the successful development and application of lab-on-a-chip devices”.6 Phospholipids vesicle
aggregates have been employed for this kind of delivery application in microfluidic devices
(Figure 7.1).

The release of the agent from these vesicles has been accomplished by a

temperature gradient that is prebuilt in the channel.6 Results in this study showed that vesicles
containing a small molecule can achieve high efficiency mixing and reagent delivery. However,
the temperature gradient vesicle breaking mechanism used in this system limited its application
in many areas. The increased temperature could not be applied to many samples including
biological and chemical agents. Furthermore, change of internal channel temperature will cause
a different reaction kinetic process, which is difficult to monitor.
The sizes of the developed Q9 vesicles ranged from 20 to 200+ nm. They can move
effortlessly inside these microsized channels. The protective nature of these vesicles will help
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transport agents in the channel safely. Thus, both a target sample and an analysis agent can be
contained and delivered with Q9 vesicles.
The packing efficiency of the Q9 vesicles needs to be enhanced for these applications to
be successful. Two strategies can be adopted for this purpose. One is to increase the Q9 vesicles
number (vesicle concentration), and the other is to increase the size (diameter) of the Q9 vesicles.
Either can enhance the encapsulation ability of Q9 vesicles.
It has been pointed out, in this dissertation, that it was difficult to produce a large number
of Q9 vesicles through the extrusion treatment compared with the phospholipids vesicles
prepared under the same conditions. This indicated the difficulties on the stabilization of the Q9
vesicles. It has been reported that the addition of the fatty alcohol compounds inside the fatty
acid vesicle solution would help to stabilize the vesicle aggregates.7 This method can be applied
to increase the lifetime of Q9 vesicles. Also, the size of Q9 vesicle would hopefully increase as
the spherical structure became more stable. The fatty alcohol that could be adopted for this
purpose should possess a similar carbon chain length as the Q9 structure.

However, fatty

alcohols with carbon chains greater that 11 are insoluble in aqueous solution, which make them
very difficult to be applied directly.
To adopt the fatty alcohol stabilization method, chemical modification should be applied
on the fatty alcohol structure. A hydrophilic moiety should be attached on the fatty alcohols
(C>11), to increase their water solubility at room temperature. The new synthesized structure are
hoped to be soluble in PBS solution and mix with Q9.
The vesicles formation should be checked through CryoEM and AF4 experiment. The
impact of the chain length and the adding ratio of the new developed water soluble additives
should be evaluated. The controllable release property of this new vesicle should be monitored
by water soluble dye encapsulation and release experiment. The vesicle composed of two
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components could perform differently from the pure Q9 vesicles in encapsulation ability. The
kinetic process of the breaking of this vesicle could be studied by NMR kinetic experiments and
fluorescence method.
After this work, it is predicted a suitable additive system can be selected.

Large

quantities of vesicles will be produced with added stability due to this new water soluble additive,
and bigger size vesicles are expected. Thus, the enhanced packing capacity will finally allow
these vesicles for more applications.
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APPENDIX 1. PRODUCTS MINIMUM PURITY CALCULATION
Appendix 1.1 Product 2

Non-product peaks intensity: 0.0090, 0.0043, 0.0059, 0.0192;
Product 2 peaks intensity: 0.0397, 0.1669, 0.2439, 0.4716, 1.2554;
Product 2 purity =
1-

∑ (0.0090,0.0043,0.0059,0.0192)
∑ (0.0397,0.1669,0.2439,0.4716,1.2554) + ∑ (0.0090,0.0043,0.0059,0.0192)

= 99.12%

93

Appendix 1.2 Product 3

Non-product peaks intensity: 0.0036, 0.0086, 0.0133, 0.0004, 0.0159, 0.0408;
Product 3 peaks intensity: 0.2589, 3.1937;
Product 3 purity =
1-

∑ (0.0036, 0.0086, 0.0133, 0.0004, 0.0159, 0.0408)
∑ (0.2589, 3.1937) + ∑ (0.0036, 0.0086, 0.0133, 0.0004, 0.0159, 0.0408)

= 98.8%
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Appendix 1.3 Product 4

Non-product peaks intensity: 0.0307, 0.011, 0.0312, 0.0467, 0.195, 0.0182, 0.0388, 0.3716;
Product 4 peaks intensity: 0.6124, 1.9429, 1.7657, 2.0247, 0.9186, 7.2643;
Product

4

purity

=

1

-

∑ (0.0307, 0.011, 0.0312, 0.0467, 0.195, 0.0182, 0.0388, 0.3716)
∑ (0.6124, 1.9429, 1.7657, 2.0247, 0.9186, 7.2643) + ∑ (0.0307, 0.011, 0.0312, 0.0467, 0.195, 0.0182, 0.0388, 0.3716)
= 95.1%
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Appendix 1.4 Product 6

Non-product peaks intensity: 0.0119, 0.0086, 0.0464, 0.0516, 0.1185;
Product 6 peaks intensity: 0.6693, 0.4489, 0.1562, 0.4273, 0.4445, 0.5464, 0.5587, 0.5225;
Product 6 purity = 1 –

∑ (0.0119, 0.0086, 0.0464, 0.0516, 0.1185)
∑ (0.0119, 0.0086, 0.0464, 0.0516, 0.1185) + ∑ (0.6693, 0.4489, 0.1562, 0.4273, 0.4445, 0.5464, 0.5587, 0.5225)

= 98.6%
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Appendix 1.5 Product 7

Non-product peaks intensity: 0.0608, 0.0047, 0.0336, 0.3153, 0.2753, 0.2071, 0.7715, 1.6683;
Product 7 peaks intensity: 18.4234, 78.5656;
Product 7 purity = 1 -

∑ (0.0608, 0.0047, 0.0336, 0.3153, 0.2753, 0.2071, 0.7715, 1.6683)
∑ (18.4234, 78.5656) + ∑ (0.0608, 0.0047, 0.0336, 0.3153, 0.2753, 0.2071, 0.7715, 1.6683)

= 98.3%

97

Appendix 1.6 Product 8

Non-product peaks intensity: 0.0087, 0.0108, 0.021, 0.0405;
Product 8 peaks intensity: 0.1567, 0.3603, 0.3448, 0.394, 0.5301, 1.07146, 2. 7314, 3.0201,
0.3847;
Product 8 purity = 1 -

∑ (0.0087, 0.0108, 0.021, 0.0405)

∑ (0.1567, 0.3603, 0.3448, 0.394, 0.5301, 1.07146, 2. 7314, 3.0201, 0.3847) + ∑ (0.0087, 0.0108, 0.021, 0.0405)
= 99.5%
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Appendix 1.7 Product 9

Non-product peaks intensity: 0.0237, 0.0331, 0.0318, 0.1321, 0.1244, 0.3592, 0.0405, 0.0378,
0.0802;
Product 9 peaks intensity: 1.7397, 81.1195;
Product 9 purity = 1 -

∑ (0.0237, 0.0331, 0.0318, 0.1321, 0.1244, 0.3592, 0.0405, 0.0378, 0.0802)
∑ (0.0237, 0.0331, 0.0318, 0.1321, 0.1244, 0.3592, 0.0405, 0.0378, 0.0802) + ∑ (1.7397, 81.1195)

= 98.9%
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